WO2000000593A2 - Sphingolipid-desaturase - Google Patents

Sphingolipid-desaturase Download PDF

Info

Publication number
WO2000000593A2
WO2000000593A2 PCT/DE1999/001859 DE9901859W WO0000593A2 WO 2000000593 A2 WO2000000593 A2 WO 2000000593A2 DE 9901859 W DE9901859 W DE 9901859W WO 0000593 A2 WO0000593 A2 WO 0000593A2
Authority
WO
WIPO (PCT)
Prior art keywords
sphingolipid
desaturase
double bond
plant
amino acid
Prior art date
Application number
PCT/DE1999/001859
Other languages
German (de)
French (fr)
Other versions
WO2000000593A3 (en
Inventor
Ernst Heinz
Ulrich ZÄHRINGER
Petra Sperling
Hermann Schmidt
Original Assignee
Gesellschaft Für Erwerb Und Verwertung Von Schutzrechten - Gvs Mbh
Forschungszentrum Borstel Zentrum für Medizin und Biowissenschaften
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gesellschaft Für Erwerb Und Verwertung Von Schutzrechten - Gvs Mbh, Forschungszentrum Borstel Zentrum für Medizin und Biowissenschaften filed Critical Gesellschaft Für Erwerb Und Verwertung Von Schutzrechten - Gvs Mbh
Priority to AU54075/99A priority Critical patent/AU5407599A/en
Publication of WO2000000593A2 publication Critical patent/WO2000000593A2/en
Publication of WO2000000593A3 publication Critical patent/WO2000000593A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083Miscellaneous (1.14.99)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the invention relates to enzymes which selectively introduce a double bond into the sphingobase of the ceramide residue of sphingolipids and of capnoids (hereinafter also called “spingolipid desaturase” or “desaturase”).
  • the invention further relates to DNA sequences coding for these sphingoiipid desaturases, the use of the sphingoiipid desaturases and the DNA sequences to change the content and / or the structure of sphingolipids, their catabolites and / or their synthetic secondary products in transgenic cells and / or organisms and a process for the preparation of sphingolipids and capnoids with unsaturated sphingobase (hereinafter also referred to as “sphingolipid”) and the sphingolipids thus obtained.
  • sphingolipid unsaturated sphingobase
  • Sphingolipids are membrane components that are found in all eukaryotic cells and only in a few bacteria.
  • the hydrophobic component, ceramide contains a long-chain base (2-amino-1,3-dihydroxyalkane) which is linked to a long-chain fatty acid via an acid amide bond.
  • ceramide residue can also be found in capnoids (1-deoxy-ceramide-1-sulfonic acid) of sliding bacteria.
  • Sphingolipids act as inter- and intracellular messengers in cell growth and differentiation, in apoptosis effects and in pathogen defense against microorganisms (AH Merrill et al., "Sphingolipids: metabolism and cell signaling", in 'Biochemistry of Lipids, Lipoproteins and Membranes', Vol 31: 309-339, DE Vance and JE Vance (ed.), Elsevier Science BV, Amsterdam (1996)).
  • Various structural modifications of the ceramide are possible; however, few genes for its enzymatic variation have been cloned to date. It was not until late 1997 that the genes for the delta-4-hydroxylase of the long-chain base (D.
  • a number of enzymes and nucleic acids are known, the amino acid sequences or DNA sequences of which are somewhat similar to the sequences according to the invention. However, these are either a) stereoselective glycerolipid desaturases or DNA sequences coding for such glycerolipid desaturases that introduce a c / s double bond into acyl residues (J. Shanklin et al., “Eight Histidine Residues Are Catalytically Essential in a Membrane-Associated Iron Enzyme, Stearoyl-CoA Desaturase, and Are conserveed in Alkane Hydroxylase and Xylene Monooxygenase ", Biochemistry 33: 12787-12794 (1994); O.
  • Sphingolipids are complex natural products with high heterogeneity that are found in plants, animals, insects, fungi and some bacteria. An inexpensive The production of homogeneous compounds on an industrial scale has so far not been possible, since corresponding genes have not yet been cloned. Since it was found that sphingolipids, as an essential component of the epidermal lipids, play a decisive role in stabilizing the barrier functions of the skin, they have meanwhile been used widely in cosmetics. However, since natural sphingolipids have to be extracted and purified by complex processes, they are very expensive, so that efforts are not lacking to even look for analog structures that can be easily synthesized from inexpensive starting materials (H.
  • the problem underlying the present invention was to provide the enzymes required for the biochemical synthesis of unsaturated sphingolipids or for the modification of sphingolipids.
  • the invention thus relates to (1) sphingoiipid desaturases which selectively introduce a double bond into the sphingobase of the ceramide residue of sphingolipids and of capnoids.
  • the sphingolipid desaturase according to the invention preferably introduces a ⁇ -6 double bond into the sphingobase.
  • ⁇ -6 is to be understood as the relative position of the double bond introduced (a double bond in position C 6 -C after the last oxygen-activated C atom (Ci); see FIG. 14).
  • delta- 4 ",” delta-8 “,” delta-9 “and” delta-10 hereinafter denote the absolute position of the double bond.
  • the enzyme according to the invention differs from the above-mentioned glycerolipid desaturases with regard to its substrate specificity (long-chain base of the sphingolipids), its regioselectivity (position of the introduced double bond delta-8 in plants or delta-8 and delta-9 in transgenic yeast) and its stereoselectivity ( ice and trans).
  • the amino acid sequence comprises one or more of the fragments a) - c) or c) - e), sphingoiipid desaturases whose amino acid sequence comprising all three fragments a) - c) or c) - e) being particularly preferred : a) HDAGH, b) HN [A, S] HH (ie HNAHH or HNSHH); c) QLEHH; d) AYX a X b HD [A, S] GH, where X a and X b are any amino acid residues, and e) THNAHH.
  • the fragment d) preferably has the sequence AYX a GHDAGH, wherein X a is any amino acid residue.
  • the desaturases according to the invention can also contain the fragments AWWKWT and / or FGGLQF.
  • the desaturases according to the invention do not include a desaturase with the amino acid sequence shown in FIG. 15.
  • Particularly preferred sphingoiipid desaturases of the present invention include the amino acid sequences shown in Fig. 2 or 4.
  • the invention further relates to (2) DNA sequences which code for the above desaturases defined in (1), the DNA sequence shown in FIG. 15 not being included.
  • the DNA sequence is preferably obtainable from Arabidopsis thaliana and Brassica napus, with DNA sequences comprising the sequences shown in FIG. 1 or 3 being particularly preferred.
  • vectors comprising the DNA sequences defined in (2) are disclosed.
  • the vectors according to the invention can be used in addition to the DNA Sequences still functional DNA sequences promoting the expression of these DNA sequences such.
  • the invention further relates to
  • cells transformed with one of the vectors defined in (3) these cells preferably being plant, fungal, bacterial or animal cells;
  • transgenic organisms which comprise a) a DNA sequence as defined above under (2), b) a vector as defined above under (3) and / or c) from a cell as above under ( 4) defined, can be generated;
  • plants or their progeny which can be generated from the plant cell as defined under (5) above, the plants preferably being useful plants and / or having a modified delta-8 base pattern;
  • a process for the production of plants which has an increased or reduced proportion or a modified cis / trans ratio of delta-8-unsaturated long-chain bases comprising a) transforming a plant cell with a DNA sequence, as described above under ( 2), including the DNA sequences from FIG. 15, and b) the regeneration of a plant with an altered delta-8 base pattern in its sphingolipids.
  • the method according to (7) is a) to compensate for a lack of delta-8-unsaturated long-chain bases in an organism b) to switch off the production of delta-8-unsaturated bases, c) to produce plants with improved tolerance and resistance against salinization and / or ionic stress or toxicity and / or drought and / or moisture and / or cold or frost and plant pathogenic microorganisms and d) suitable for the production of plants with changed size growth and flowering time.
  • sphingolipids e.g. B. the above-mentioned gene from A.
  • thaliana in antisense orientation and the above-mentioned gene from B. napus in sense orientation (co-suppression) can be cloned into a constitutive plant expression vector.
  • the transformation of A. thaliana then takes place e.g. B. with the help of Agrobacterium fcvme ac / ens-mediated in planta vacuum infiltration (N. Bechthold et al., "In Planta Agrobacterium mediated gene transfer by infiltration of adult Arabidopsis thaliana plants", CR Acad.
  • the invention further relates to
  • sphingolipids and capnoids with unsaturated sphingobase, comprising culturing cells, organisms or plants as defined in (4) - (6) above.
  • the method further includes isolating the sphingolipids from the culture.
  • the sphingolipid produced is preferably a compound of the formula (I)
  • R 1 is -OH, -OPO 3 HR 6 , a carbohydrate residue or -S0 3 H;
  • R 2 is a dC 33 alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more hydroxyl radicals;
  • R 2 is preferably a C 1 -C 2 -alkyl radical and R 4 is a C 3 -Ci2-alkyl radical, in particular a C 7 -, Cg- or Cn-alkyl radical.
  • a carbohydrate residue in the sense of the present invention consists of one or more glycosidically linked aldopentoses, aldohexoses, ketohexoses and the amino, urone and deoxy derivatives derived therefrom.
  • Polyhydroxy compounds are to be understood as radicals derived from alkane polyols such as glycol, glycerol and mannitol.
  • Aminoalkyl radicals for the purposes of the present invention are 2-aminoethyl and 2- (trimethylammonium) alkyl radicals.
  • the sphingolipid produced is a compound of the formula (II)
  • R 1 , R 2 , R 3 , a and b have the meaning given above.
  • the invention thus also relates to (9) spingobases and capnoids with unsaturated sphingobase with the formula
  • R 2 is a -CC 33 alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more hydroxyl radicals;
  • R 4 is -H or a Ci-Cis-alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more methyl radicals;
  • R 6 is -H, a polyhydroxyalkyl group, an aminoalkyl group or a carbohydrate group; and either a, b or c is a double bond,
  • “Derivatives” are to be understood as products from chemical or enzymatic reactions, with this reaction the molecular weight of the sphingobase can both be increased (eg by O-acylation and hydroxylation of double bonds) and reduced by cleavage reactions (eg by splitting off the fatty acid residue of the ceramide residue). “Derivative” is therefore also to be understood as the free sphingobase.
  • R 1 , R 2 , R 3 , R 4 , R 5 , b and c have the meaning given above.
  • the invention relates to (10) cosmetics, pharmaceuticals or foodstuffs or chemical raw materials which comprise a compound as produced according to method (8) or as defined in (9).
  • Medicines include agents for regulating blood pressure and heart rhythm, for modulating insulin secretion, agents for wound healing, agents with anti-tumor activity, protective action against radioactivity, stimulation of cell growth, influencing leukocyte differentiation, immunoreceptors for viruses, bacterial and mycotoxins.
  • the numerous human sphingolipid storage diseases such as. B. Niemann-Pick and Tay-Sachs disease, also put an application as therapeutic effective fine chemical close to humans, with a high pharmacological, toxicological and nutritional potential.
  • microorganisms such as. B. yeasts and fungi
  • their phyto- and / or human pathogenicity could be reduced.
  • heterologous expression of the plant sphingolipid desaturase in microorganisms such as. B. Baker's, brewer's yeast and their mutants (RC Dickson et al., "Isolation of mutant Saccharomyces cerevisiae strains that survive without sphingolipids", Mol. Cell Biol.
  • Fig. 2 Reduced amino acid sequence (449 aa) of the sphingolipid desaturase from ⁇ . napus.
  • Fig. 4 Reduced amino acid sequence (449 aa) of the sphingolipid desaturase from A. thaliana.
  • Fig. 5 Protein sequence comparisons of the Sphingoiipid desaturases from ⁇ . napus (BnDES ⁇ , Fig. 2), A. thaliana (AtDES8, Fig. 4) and sunflower (HaDES ?, (Sperling et al., 1995), Fig. 15) with the delta-6 glycerolipid desaturase from Borage (B0DES6 (Sayanova et al., 1997)).
  • the N-terminal domain up to position 121 of the sunflower sequence is homologous to the hydrophilic part of cytochrome b 5 , the conserved amino acids of which are underlined.
  • the three highly conserved histidine boxes (Shanklin et al., 1994), which are characteristic of lipid desaturases, are shown. Identical amino acids are highlighted by gray shading.
  • Fig. 8 Formation of phytosphine genes in yeast cells by heterologous expression of plant sphingoiipid desaturases.
  • the long-chain bases (LCB) of the sphingolipids were obtained from whole cells by strong alkaline hydrolysis (Morrison and Hay, 1970), converted into their dinitrophenyl derivatives (Karisson, 1970) and analyzed by RP-HPLC.
  • A Separation of the reference substances (Sigma) phytosphinganine (t18: 0), 4-rrans-sphingenine (d18: 1) and sphinganine (d18: 0).
  • B LCB pattern of the wild-type yeast cells (INVSd) or transformed with the empty vector pYES2.
  • eis- and frans-phytosphingenin (t18: 1) in yeast cells which contain either (C) the A.thaliana fusion protein (pYES2At) or (D) the ß. express napus fusion protein (pYES2Bn). (E) LCB pattern of A. thaliana (wild type) plants.
  • Fig. 10 Partial 1 H-NMR spectra (600 MHz) of (A) trans- ⁇ 8 ' 9 - and (B) cis- ⁇ 8 ' 9 - phytosphingenin. The signals were assigned using COZY experiments.
  • Fig. 12 Vector construct for homologous antisense suppression of the s / c 1 gene from A. thaliana (pBIB5At) in A. thaliana.
  • Fig. 13 Suppression of delta-8 sphingolipid desaturation in transgenic A. thaliana plants.
  • the long-chain bases (LCB) of the sphingolipids were obtained from mixed samples (350 mg fresh weight) of whole T2 plants, 34 d after germination, by strong alkaline hydrolysis (Morrison and Hay, 1970) and converted into their dinitrophenyl derivatives (Karisson, 1970) and analyzed by RP-HPLC.
  • Fig. 14 Regioselectivity of the plant sphingolipid desaturase.
  • the ⁇ -6-sphingolipid desaturases introduce a delta-8 and -9 double bond in the eis and frans configuration into long-chain bases, which leads to the formation of phytosphingenin or phytosphinginin-containing sphingolipids (t18: 1) in the transformed yeast cells (R represents a variety of possible fatty acid residues).
  • LCB long chain bases (of the sphingolipids) mRNA messenger ribonucleic acid
  • Example 1 Isolation and cloning of S / Q * 1 from B.napus
  • E. coli XL1 blue, MRF '(Stratagene) was at 37 ° C in LB medium (J. Sambrook et al., "Molecular Cloning: A Laboratory Manual", 2nd edn., Cold Spring Harbor Laboratory Press, USA (19 ⁇ 9
  • the antibiotics ampicillin (100 ⁇ g / ml) and kanamycin (30 ⁇ g / ml) were added to the medium, and competent E. coli were transformed according to H. Inoue et al.
  • BN1 ( ⁇ '-G [GC] [ATGC] TGGTGGAA [AG] TGG-3 ') and BN2 ( ⁇ '-GG [AG] AA [ATGC] A [AG] [AG] TG [AG] TG-3' ) used, which correspond to the amino acid sequences [GA] WWKW and HHLFP from H.annuus.
  • the following program was used for the amplification: ⁇ min at 96 ° C, followed by 30 cycles of 20 s at 96 ° C, 1 min at 40 ° C (binding temperature, T m ) and 2 min at 72 ° C, 1 cycle of 10 min at 72 ° C.
  • T m binding temperature
  • Gibco BRL used the TaG / DNA polymerase for the amplification.
  • the ⁇ 'end of the cDNA was treated with the Stratagene T3 primer (20 mer) and the specific back primer
  • BN3 ( ⁇ '-TTATGCGTCCATTTCCACCA-3 ') amplified by PCR as described, except that the Tm was ⁇ ° C.
  • cDNA was made from mRNA maturing embryos of ß. napus cv. Drakkar used.
  • mRNA was extracted from ß maturing embryos using oligo (dT) Dynabeads according to the instructions for use from Dynal GmbH (Hamburg).
  • oligo (dT) Dynabeads according to the instructions for use from Dynal GmbH (Hamburg).
  • napus cv. Drakkar isolated. This mRNA was converted into a single-strand cDNA synthesis using the reverse transcriptase reaction using the SuperScript preamplification system (Gibco BRL) and a synthetic oligo (dT) primer
  • Example 2 Isolation and cloning of s / dl from A. thaliana
  • a TBLASTN search SF Altschul et al., "Basic local alignment search tool", J. Mol. Biol. 215: 403-410 (1990)
  • Fig. 2. Parts of the protein sequence from ß.napus showed a significant similarity to the following EST clones from A.
  • thaliana whose EMBL accession numbers are: T42569 (27-93), N37 ⁇ 8 (33-196), F13726 (113-201), T42306 (366-396), F13717 (421-449).
  • the numbers in brackets refer to to the amino acid positions of the rapeseed sequence (Fig. 2) covered by these EST clones.
  • oligonucleotide primers were derived from the nucleotide sequences of the EST clones
  • the ⁇ 'or 3' end was amplified by means of the above-mentioned PCR (T m 60 ° C.) with the primer combination T3 primer (Stratagene) and AT2 or T7 primer and AT1.
  • the 1272 bp DNA fragment (PCR clone 3) was converted into pUC 19 / Smal and the 5 'and 3' DNA fragments were analyzed with the pGEM-T Vector System (Promega) in E. coli XLIblue (MRF ⁇ Stratagene ) cloned.
  • the sequencing was carried out using the ABI PRISM Dye Primer Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Rothstadt).
  • AT3 forward: ⁇ '-CCGGTACCATGGCGGAAGAGACGGAG-3 'and AT4, reverse: ⁇ '-CCGAATTC TTAGCCATGAGTATTCAAAGC-3'
  • the two derived polypeptides of approx. 61-62 kD have 76% identical amino acids to each other and 6 ⁇ % and 64% to the sunflower sequence.
  • Example 3 Cloning and expression of s / c / 1 in Saccharomyces cerevisiae: The cloning and expression of s / c 1 was based on the successful expression method of the fac / 2 gene from A. thaliana in yeast (S. Kajiwara et al ., "Polyunsaturated fatty acid biosynthesis in Saccaromyces cerecisiae: Expression of Ethanol Tolerance and the FAD2 Gene from Arabidopsis thaliana", Appl. Environ. Microbiol. 62: 4309-4313 (1996)). The amplified s / c / 1 DNA from ß napus and A.
  • thaliana (PCR clones 2 and 4), which had been cloned into the multiple cloning site of the vector pGEM-T vector (Promega) (see above), were cut with the restriction endonucleases Kpnl and EcoRI Kpnl / EcoRI- Fragments were inserted into the Kpnl / EcoRI site of the zipped yeast E. coli shuttle expression vector pYES2 alloyed (Invitrogen Co.). The resulting new plasmids, pYES2Bn and pYES2At, are shown in Fig. 6 and Fig. 7 and were transformed into E. coli TOP10F '(Invitrogen Co.).
  • the DNA maxi preparation was carried out with the plasmid Maxi Kit (Qiagen).
  • the isolated plasmids pYES2Bn and pYES2At were checked again with the ABI PRISM Dye Primer Ready Reaction Kit (Perkin-Elmer) and then in S. cerevisiae INVSd (Invitrogen Co.) with the polyethylene glycol method (M. von Pein, dissertation, Heinrich Heine University Düsseldorf (1992)) transformed.
  • CM complete minimal dropout uracil
  • CM complete minimal dropout uracil
  • glucose FM Asubel et al., "Current Protocols in Molecular Biology", John Wiley & Sons, New York 1996.
  • the review of the transgenic Yeast colonies were carried out by means of a mini preparation of yeast plasmid DNA (Asubel et al. (1996), see above) whose retransformation in E. coli TOP10F ', subsequent mini preparation and restriction analysis of the E.co// ' plasmid DNA with Kpnl / EcoRI the analytical comparison of the transformants with the wild-type yeast also transformed the uncut pYES2 vector into INVSd (control).
  • the preculture was carried out by inoculating 2- ⁇ ml of CM- 2% raffinose medium with a transgenic yeast colony and then incubating for 2 d at 30 ° C. in a roller up to an optical density at 600 nm (OD ⁇ oo) of 4- ⁇ .
  • CM-2% raffinose medium was inoculated with an aliquot of the preculture (600-fold dilution) to OD 60 or 0.01-0.02 and incubated in the shaker at 30 ° C., 2 ⁇ 0 rpm for 24 h.
  • the test cultures were induced in the logarithmic growth phase (OD 6 oo 0.1-0.6) by adding galactose ad 1.8%.
  • the induced cells were harvested after a further 24 h of aerobic growth at 30 ° C. at OD 60 o 4- ⁇ .
  • Example 4 Analysis of the long-chain bases from the sphingolipids of the yeast transformants The induced yeast cells were harvested by centrifugation at 2000 g for 10 min, twice with distilled water. washed, 20 min in distilled water boiled, and sedimented again after cooling on ice.
  • the long-chain bases were obtained by strong alkaline hydrolysis (24 h at 110 ° C) of whole cells (350 mg fresh weight) in 10% Ba (OH) 2 / dioxane (1 : 1, v / v) released (WR Morrison et al., "Polar lipids in bovine milk II.
  • the dinitrophenyl LCBs were extracted with CHCI 3 / methanol / H 2 0 ( ⁇ : 4: 3), purified by thin layer chromatography in CHCI 3 / methanol (90:10) (K.-A. Karisson (1970), see above) and with Methanol extracted from the silica gel.
  • RP-HPLC reverse phase high performance liquid chromatography
  • the different species were separated using an ODS Hypersil ® RP1 ⁇ column (5 ⁇ m, 26 x 4.6 cm) from Bischoff. Elution was carried out using a linear gradient at a flow rate of 1 ml / min: from 80% methanol / acetonitrile / 2-propanol (10: 3: 1, v / v / v) and 20% distilled water. to 0% aqua dest. in 40 min.
  • the elution of the dinitrophenyl derivatives was detected at 360 nm in proportion to the mass (FIG. 8).
  • the reference LCB were obtained from Sigma (FIG.
  • Example ⁇ Analysis of the novel long-chain sphingobases using NMR and MS Isolation and derivatization of the phytosphine genes:
  • the LCB were isolated from transgenic yeast cells ( ⁇ , 7 g fresh weight) by means of alkaline hydrolysis (see Example 4).
  • the fraction of the free C1 ⁇ trihydroxy bases was separated from the remaining bases of the hydrolyzate by thin layer chromatography in CHCI 3 / methanol / NH 4 (40: 40: 1) (M. Ohnishi et al. , Biochim. Biophys.
  • the per-O-acetylated C13-trihydroxy bases were extracted in n-hexane against water (1: 1) and purified by thin layer chromatography in 100% diethyl ether, detection with 0.2% methanolic ⁇ -anilinonaphthalene-1-sulfonic acid under UV light and extraction with n -Hexane:
  • GC-MS Mass spectroscopy
  • a Hewlett-Packard model 5989 spectrometer with an HP-5 capillary column (30 m x 0.2 ⁇ mm).
  • the following temperature gradients were used for the analysis of the various derivatives: Per-O-acetylated phytosphingenins: 3 min at 230 ° C, gradient from ⁇ ° C / min to 330 ° C and medium-chain fatty acid methyl ester: 3 min at 100 ° C, gradient from 10 ° C / min to 330 ° C.
  • GC-MS analysis was carried out in Cl (with ammonia) and El mode (70 eV).
  • A) Lead tetraacetate oxidation An aliquot of the unfractionated, peracetylated C18-trihydroxy bases (0.36 mg) were desacyated with sodium methylate and then oxidized with Pb (OAc) 4 in chloroform. The resulting aldehydes were extracted into chloroform, evaporated to dryness and reduced to the corresponding alcohols with LiAIH in ether. 1/10 of the alcohols were converted into their trimethylsilyl derivatives with BSTFA (Sigma) and analyzed directly by GC-MS. The remaining alcohols (9/10) were converted to nicotinates with nicotinic acid chloride in pyridine, extracted into water in n-hexane and analyzed by GC-MS.
  • the fraction of the per-O-acetylated C1 ⁇ -trihydroxy bases from the yeast transformed with pYES2At was analyzed by GC-MS, whereby three distinct peaks were obtained. A peak eluting at 15.72 min was identified as 2-N-acetamido-1, 3,4-tri-O-acetyl-octadecane (phytosphinganine, t1 ⁇ : 0).
  • the fraction of the C13 trihydroxy bases was oxidized with potassium permanganate and converted into its fatty acid methyl ester (FAME).
  • a methyl pentadecanoate (C15: 0) was obtained from the per-O-acetylated t1 ⁇ : 0 due to the oxidation of the diol groups between C3 and C4.
  • two medium-chain FAME were obtained and identified by GC-MS as nonanoic acid methyl ester (C9: 0, 7.5 min) and decanoic acid methyl ester (C10: 0, 9.0 min).
  • Both fatty acids were present in a ratio of 1: 3, from which it follows that in the original sample there were two phytosphingenin isomers (t1 ⁇ : 1 8 and t1 ⁇ : 1 9 ) with different positions of the double bond in positions delta- ⁇ and -9.
  • Example 6 Cloning and transformation of s / d1 in Arabidopsis thaliana For heterologous overexpression of the s / d1 gene from ß.
  • the 1 ⁇ 02 bp PCR clone 1 was cloned into puc19 / Smal (see Example 1) and cut with the restriction enzymes BamHI and SacI.
  • the resulting 1621 bp DNA fragment was alloyed in a sense orientation in the BamBI and Sacl-cut plant expression vector pBI121 from CLONTECH behind the constitutive 35S promoter (CaMV) instead of the GUS gene.
  • the resulting plasmid pBIB ⁇ Bn is shown in Fig. 11.
  • the plasmids pBIB ⁇ Bn and pBIB ⁇ At were transformed into E. coli XLIblue and a DNA maxipreparation was carried out with the plasmid Maxi Kit (Qiagen).
  • the completeness and correct orientation of the PCR clones in pBIB ⁇ Bn and pBIB ⁇ At was checked on the one hand by various restriction digests (BamHI + Sacl, BamHI + EcoRI; Xbal + Sacl) and on the other hand by repeated partial sequencing the ABI PRISM Dye Terminator Kit (Perkin-Elmer) at T m ⁇ O ° C and the following specific primers:
  • 3 ⁇ S promoter primer PR01 ⁇ '-CACAATCCCACTATCCTT-3 '(forward)
  • BN9 ⁇ '-GGAGCTTTGTAAGAAGCAT-3' (reverse) and AT ⁇ : 5'-GGAATCTCAATCGCGTGG-3 '(reverse).
  • the Agrobacterium tumefaciens strain GV3101 with the Ti helper plasmid pMP90 (C. Koncz et al., "The promotor of T L -DNA gene ⁇ controls the tissue-specific expression of chimaeric genes by a novel type of Agrobacterium binary vector", Mol. Gen Genet. 204: 363-396 (1986)) was each with one of the binary vectors pBI121 (control), pBIB ⁇ Bn and pBIB ⁇ At according to the method of H. Chen et al., "Enhanced Recovery of Transformation of Agrobacterium tumefaciens after Freeze-Thaw Transformation and Drug Selection ", BioTechniques 16: 664-669 (1994).
  • the transformed bacteria were grown for 24 h at 28 ° C. in Luria-Bertani (LB) selective medium with 100 ⁇ g / ml rifampicin, 40 ⁇ g / ml gentamycin and 50 ⁇ g / ml kanamycin (Sigma). After the antibiotic selection on LB agar plates, positive single colonies were checked by means of PCR at T m 50 ° C. with the following primer combinations: PR01 and BN6 for pBIB5Bn; PR01 and AT1 for pBIB ⁇ At.
  • the transformation of whole A. thaliana plants, ecotype Columbia (C24) was carried out in planta by / Agroöacter / wm-mediated vacuum infiltration (N. Bechthold et al. (1993), and modified by AF Bent et al. (1994), see above) )
  • Example 7 Cultivation and selection of the transgenic rafe / dojPS / s plants
  • the A / rofeacter / um-infiltrated TO plants were grown in pots with uniform earth / sand (2: 1) in the climatic chamber under long-day conditions (16 h light) at 22 ° C day and 17 ° C night temperature and 60% humidity grown to maturity and the T1 seeds harvested together.
  • the dried seeds were surface-sterilized with 4% NaOCI in 0.02% Triton ® X-100, on selective nutrient medium (1x MS salts incl. Gamborg's Vit.
  • Example ⁇ Analysis of the LCB from the sphingolipids of transgenic Arabidopsis plants
  • the LCB analyzes of the mixed samples showed that the content of eis- and frans-phytosphingenin (t1 ⁇ : 1) in the total sphingolipids from ⁇ O- ⁇ % in wild type or in T2 control plants (+ pBI121) to up to ⁇ % in T2 plants with pBIB ⁇ At (antisense) or pBIB ⁇ Bn (sense) was reduced (Fig. 13). While the antisense effect in T2 plants with pBIB ⁇ Bn (sense) is due to co-suppression effects (Review by J.
  • the antisense effect leads to a drastic reduction of these LCB species in the sphingophosphoglycolipids.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to enzymes which selectively introduce a double bond in the sphingobase of the ceramide residual of sphingolipids and of capnoids. The invention also relates to DNA sequences which code for these enzymes, to the use of the enzymes and DNA sequences for modifying the content and/or the structure of sphingolipids, the catabolites thereof and/or their synthetic subsequent products in transgenic cells and/or organisms. In addition, a method is provided for producing sphingolipids and capnoids with an unsaturated sphingobase.

Description

Bezeichnung: Sphingolipid-DesaturaseName: Sphingolipid desaturase
Die Erfindung betrifft Enzyme, die selektiv eine Doppelbindung in die Sphingobase des Ceramidrestes von Sphingolipiden und von Capnoiden einführen (nachfolgend auch kurz „Spingolipid-Desaturase" oder „Desaturase" genannt). Die Erfindung betrifft weiterhin für diese Sphingoiipid-Desaturasen kodierende DNA-Seqenzen, die Verwendung der Sphingoiipid-Desaturasen und der DNA-Sequenzen zur Veränderung des Gehaltes und/oder der Struktur von Sphingolipiden, deren Katabolite und/oder deren synthetischer Folgeprodukte in transgenen Zellen und/oder Organismen sowie ein Verfahren zur Herstellung von Sphingolipiden und von Capnoiden mit ungesättigter Sphingobase (nachfolgend auch „Sphingolipid") und die so erhaltenen Sphingolipide.The invention relates to enzymes which selectively introduce a double bond into the sphingobase of the ceramide residue of sphingolipids and of capnoids (hereinafter also called “spingolipid desaturase” or “desaturase”). The invention further relates to DNA sequences coding for these sphingoiipid desaturases, the use of the sphingoiipid desaturases and the DNA sequences to change the content and / or the structure of sphingolipids, their catabolites and / or their synthetic secondary products in transgenic cells and / or organisms and a process for the preparation of sphingolipids and capnoids with unsaturated sphingobase (hereinafter also referred to as “sphingolipid”) and the sphingolipids thus obtained.
Sphingolipide sind Membrankomponenten, die in allen eukaryoten Zellen und nur in wenigen Bakterien vorkommen. Der hydrophobe Bestandteil, das Ceramid, enthält eine langkettige Base (2-Amino-1 ,3-dihydroxy-alkan), die über eine Säureamidbindung mit einer langkettigen Fettsäure verknüpft ist. Anhand der polaren Kopfgruppe unterscheidet man Sphingophosphatide, Sphingoglycolipide, und Sphingophosphoglycolipide. Ein solcher Ceramidrest ist weiterhin in Capnoiden (1-Deoxy-ceramid-1-sulfonsäure) gleitender Bakterien zu finden. Auch dort sind entsprechende Enzyme für die Desaturierung von Capnoiden in gleitenden Bakterien verantwortlich (R. A. Drijber et al., „Cytophaga hutchinsonii ATCC 33406 contains a structural variant of the sulfonolipid N-acylcapnine", Can. J. Microbiol. 43: 689-6931997).Sphingolipids are membrane components that are found in all eukaryotic cells and only in a few bacteria. The hydrophobic component, ceramide, contains a long-chain base (2-amino-1,3-dihydroxyalkane) which is linked to a long-chain fatty acid via an acid amide bond. A distinction is made between sphingophosphatides, sphingoglycolipids and sphingophosphoglycolipids based on the polar head group. Such a ceramide residue can also be found in capnoids (1-deoxy-ceramide-1-sulfonic acid) of sliding bacteria. Corresponding enzymes are also responsible there for the desaturation of capnoids in sliding bacteria (RA Drijber et al., "Cytophaga hutchinsonii ATCC 33406 contains a structural variant of the sulfonolipid N-acylcapnine", Can. J. Microbiol. 43: 689-6931997) .
Sphingolipide fungieren als inter- und intrazelluläre Botenstoffe bei Zellwachstum und -differenzierung, bei Apoptosiseffekten und bei der Pathogenabwehr von Mikroorganismen (A. H. Merrill et al., „Sphingolipids: metabolism and cell signalling", in 'Biochemistry of Lipids, Lipoproteins and Membranes', Vol. 31: 309-339, D. E. Vance und J. E. Vance (Hrsg.), Elsevier Science B. V., Amsterdam (1996)). Diverse strukturelle Modifikationen des Ceramids sind möglich; jedoch sind nur wenige Gene für dessen enzymatische Variation bislang kloniert worden. So ist es erst Ende 1997 gelungen, die Gene für die delta-4-Hydroxylase der langkettigen Base (D. Haak et al., „Hydroxylation of Saccharomyces cerevisiae Ceramide Requires Sur2p and Scs7p", J. Biol. Chem. 272: 29704-29710 (1997)) und für die alpha-Hydroxylase der langkettigen Fettsäure (A. G. Mitchell et al., „Fahlp, a Saccharomyces cerevisiae Cytochrome b5 Fusion Protein, and Its Arabidopsis thaliana Homolog that Lacks the Cytochrome b5 Domain Both Function in the α- hydroxylation of Sphingolipid-associated Very Long Chain Fatty Acids", J. Biol. Chem. 272: 28281-28288 (1997)) zu identifizieren. Es ist jedoch noch kein Gen oder DNA-Sequenz bekannt, das bzw. die für eine Sphingolipid-Desaturase kodiert.Sphingolipids act as inter- and intracellular messengers in cell growth and differentiation, in apoptosis effects and in pathogen defense against microorganisms (AH Merrill et al., "Sphingolipids: metabolism and cell signaling", in 'Biochemistry of Lipids, Lipoproteins and Membranes', Vol 31: 309-339, DE Vance and JE Vance (ed.), Elsevier Science BV, Amsterdam (1996)). Various structural modifications of the ceramide are possible; however, few genes for its enzymatic variation have been cloned to date. It was not until late 1997 that the genes for the delta-4-hydroxylase of the long-chain base (D. Haak et al., "Hydroxylation of Saccharomyces cerevisiae Ceramide Requires Sur2p and Scs7p", J. Biol. Chem. 272: 29704- 29710 (1997)) and for the alpha-hydroxylase of the long-chain fatty acid (AG Mitchell et al., "Fahlp, a Saccharomyces cerevisiae Cytochrome b 5 Fusion Protein, and Its Arabidopsis thaliana Homolog that Lacks the Cytochrome b 5 Domain Both Function in the α - hydroxylation of sphingolipid-associated Very Long Chain Fatty Acids ", J. Biol. Chem. 272: 28281-28288 (1997)). However, no gene or DNA sequence that codes for a sphingolipid desaturase is known.
Zwar sind eine Reihe von Enzymen und Nukleinsäuren bekannt, deren Aminosäurensequenzen bzw. DNA-Sequenzen eine gewisse Ähnlichkeit mit den erfindungsgemäßen Sequenzen besitzen. Es handelt es sich jedoch hierbei entweder a) um stereoselektive Glycerolipid-Desaturasen bzw. um für solche Glycerolipid-Desaturasen kodierende DNA-Sequenzen, die eine c/s-Doppelbindung in Acylreste einführen (J. Shanklin et al., „Eight Histidine Residues Are Catalytically Essential in a Membrane-Associated Iron Enzyme, Stearoyl-CoA Desaturase, and Are Conserved in Alkane Hydroxylase and Xylene Monooxygenase", Biochemistry 33: 12787-12794 (1994); O. Sayanova et al., „Expression of a borage desaturase cDNA containing an N-terminal cytochrome b5 domain results in the accumulation of high levels of Δ6-desaturated fatty acids in transgenic tobaco", Proc. Natl. Acad. Sei. USA 94: 4211-4216 (1997); und WO 96/21022) und nicht um Sphingoiipid- Desaturasen, oder b) um DNA-Sequenzen bei denen die enzymatische Funktion des davon kodierten Proteins unbekannt ist (P. Sperling et al., „A cytochrome-b5- containing fusion protein similar to plant acyl lipid desaturases", Eur. J. Biochem. 232: 798-805 (1995)). Weiterhin sind DNA-Seqzenzen von Arabidopsis thaliana als EST-Klone in Genbanken veröffentlicht (EMBL Accession Numbers: T42569, N37558, F13728, T42806 und F13717).A number of enzymes and nucleic acids are known, the amino acid sequences or DNA sequences of which are somewhat similar to the sequences according to the invention. However, these are either a) stereoselective glycerolipid desaturases or DNA sequences coding for such glycerolipid desaturases that introduce a c / s double bond into acyl residues (J. Shanklin et al., “Eight Histidine Residues Are Catalytically Essential in a Membrane-Associated Iron Enzyme, Stearoyl-CoA Desaturase, and Are Conserved in Alkane Hydroxylase and Xylene Monooxygenase ", Biochemistry 33: 12787-12794 (1994); O. Sayanova et al.," Expression of a borage desaturase cDNA containing an N-terminal cytochrome b 5 domain results in the accumulation of high levels of Δ 6 -desaturated fatty acids in transgenic tobaco ", Proc. Natl. Acad. Sei. USA 94: 4211-4216 (1997); and WO 96 / 21022) and not sphingoiipid desaturases, or b) DNA sequences in which the enzymatic function of the protein encoded by it is unknown (P. Sperling et al., “A cytochrome-b 5 - containing fusion protein similar to plant acyl lipid desaturases ", Eur. J. Biochem 232: 798-805 (1995)). Furthermore, DNA sequences of Arabidopsis thaliana have been published as EST clones in gene banks (EMBL Accession Numbers: T42569, N37558, F13728, T42806 and F13717).
Sphingolipide sind komplexe Naturstoffe mit hoher Heterogenität, die in Pflanzen, Tieren, Insekten, Pilzen und einigen Bakterien gefunden werden. Eine preiswerte Herstellung homogener Verbindungen im großtechnischen Maßstab war bislang nicht möglich, da entsprechende Gene noch nicht kloniert waren. Seit gefunden wurde, daß Sphingolipide als ein wesentlicher Bestandteil der epidermalen Lipide eine entscheidene Rolle bei der Stabilisierung der Barrierefunktionen der Haut spielen, werden sie inzwischen weitverbreitet in der Kosmetik eingesetzt. Da natürliche Sphingolipide durch aufwendige Verfahren extrahiert und gereinigt werden müssen, sind sie allerdings sehr teuer, so daß es nicht an Bemühungen fehlt, sogar analoge Strukturen zu suchen, die sich aus preisgünstigen Edukten leicht synthetisieren lassen (H. Möller et al., „Neue Pseudoceramide durch Verknüpfung von speziellen Fettstoffen mit Kohlenhydrat-Derivaten", Abstract und Kurzreferat präsentiert auf der Tagung der Deutschen Gesellschaft für Fettwissenschaft e.V. (DGF) 'Innovation durch Kombination: Fette-Kohlenhydrate-Proteine', Bremen, 7. Okt. 1996).Sphingolipids are complex natural products with high heterogeneity that are found in plants, animals, insects, fungi and some bacteria. An inexpensive The production of homogeneous compounds on an industrial scale has so far not been possible, since corresponding genes have not yet been cloned. Since it was found that sphingolipids, as an essential component of the epidermal lipids, play a decisive role in stabilizing the barrier functions of the skin, they have meanwhile been used widely in cosmetics. However, since natural sphingolipids have to be extracted and purified by complex processes, they are very expensive, so that efforts are not lacking to even look for analog structures that can be easily synthesized from inexpensive starting materials (H. Möller et al., “Neue Pseudoceramides by Linking Special Fats with Carbohydrate Derivatives ", abstract and short presentation presented at the conference of the German Society for Fat Science eV (DGF) 'Innovation through combination: fat carbohydrate proteins', Bremen, October 7th, 1996).
Die der vorliegenden Erfindung zugrundeliegende Aufgabe bestand darin, zur biochemischen Synthese von ungesättigten Sphingolipiden bzw. für die Modifikation von Sphingolipiden benötigte Enzyme zur Verfügung zu stellen.The problem underlying the present invention was to provide the enzymes required for the biochemical synthesis of unsaturated sphingolipids or for the modification of sphingolipids.
Überraschenderweise wurde gefunden, daß gewisse aus den Pflanzen Arabidopsis thaliana und Brassica napus isolierte cDNA-Sequenzen für Sphingoiipid- Desaturasen kodieren, mit denen Sphingolipide mit unterschiedlicher Regio- und Stereoisomerie der Doppelbindung in der Sphingobase zugänglich sind.Surprisingly, it was found that certain cDNA sequences isolated from the plants Arabidopsis thaliana and Brassica napus code for sphingoiipid desaturases with which sphingolipids with different regio- and stereoisomerism of the double bond in the sphingobase are accessible.
Die Erfindung betrifft somit (1) Sphingoiipid-Desaturasen die selektiv eine Doppelbindung in die Sphingobase des Ceramidrestes von Sphingolipiden und von Capnoiden einführen. Die erfindungsgemäße Sphingolipid-Desaturase führen bevorzugt eine Δ-6 Doppelbindung in die Sphingobase ein. Unter „Δ-6" ist in der vorliegenden Anmeldung die relative Position der eingeführten Doppelbindung zu verstehen (eine Doppelbindung in Position C6-C nach dem letzten sauerstoffaktivierten C-Atom (C-i); siehe Figur 14). Daneben wird mit „delta-4", „delta- 8", „delta-9" und „delta-10" im nachfolgenden die absolute Position der Doppelbindung bezeichnet. Das erfindungsgemäße Enzym unterscheidet sich von den o.g. Glycerolipid-Desaturasen hinsichtlich seiner Substratspezifität (langkettige Base der Sphingolipide), seiner Regioselektivität (Position der eingeführten Doppelbindung delta-8 bei Pflanzen bzw. delta-8 und delta-9 in transgener Hefe) und seiner Stereoselektivität (eis und trans).The invention thus relates to (1) sphingoiipid desaturases which selectively introduce a double bond into the sphingobase of the ceramide residue of sphingolipids and of capnoids. The sphingolipid desaturase according to the invention preferably introduces a Δ-6 double bond into the sphingobase. In the present application, “Δ-6” is to be understood as the relative position of the double bond introduced (a double bond in position C 6 -C after the last oxygen-activated C atom (Ci); see FIG. 14). In addition, “delta- 4 "," delta-8 "," delta-9 "and" delta-10 "hereinafter denote the absolute position of the double bond. The enzyme according to the invention differs from the above-mentioned glycerolipid desaturases with regard to its substrate specificity (long-chain base of the sphingolipids), its regioselectivity (position of the introduced double bond delta-8 in plants or delta-8 and delta-9 in transgenic yeast) and its stereoselectivity ( ice and trans).
In einer bevorzugten Ausführungsform umfaßt die Aminosäuresequenz eine oder mehrere der Fragmente a) - c) oder c) - e), wobei solche Sphingoiipid-Desaturasen besonders bevorzugt sind, deren Aminosäuresequenz alle drei Fragmente a) - c) oder c) - e) umfaßt: a) HDAGH, b) HN[A,S]HH (d. h. HNAHH oder HNSHH); c) QLEHH; d) AYXaXbHD[A,S]GH, wobei Xa und Xb beliebige Aminosäurereste sind, und e)THNAHH.In a preferred embodiment, the amino acid sequence comprises one or more of the fragments a) - c) or c) - e), sphingoiipid desaturases whose amino acid sequence comprising all three fragments a) - c) or c) - e) being particularly preferred : a) HDAGH, b) HN [A, S] HH (ie HNAHH or HNSHH); c) QLEHH; d) AYX a X b HD [A, S] GH, where X a and X b are any amino acid residues, and e) THNAHH.
Das Fragment d) weist vorzugsweise die Sequenz AYXaGHDAGH auf, wobei Xa ein beliebiger Aminosäurerest ist. Neben den Fragmenten a) - e) können die erfindungsgemäßen Desaturasen auch noch die Fragmente AWWKWT und/oder FGGLQF enthalten.The fragment d) preferably has the sequence AYX a GHDAGH, wherein X a is any amino acid residue. In addition to fragments a) - e), the desaturases according to the invention can also contain the fragments AWWKWT and / or FGGLQF.
Die erfindungsgemäßen Desaturasen umfassen dabei nicht eine Desaturase mit der in Fig. 15 gezeigten Aminosäuresequenz. Besonders bevorzugte Sphingoiipid- Desaturasen der vorliegenden Erfindung umfassen die in Fig. 2 oder 4 gezeigte Aminosäuresequenzen.The desaturases according to the invention do not include a desaturase with the amino acid sequence shown in FIG. 15. Particularly preferred sphingoiipid desaturases of the present invention include the amino acid sequences shown in Fig. 2 or 4.
Die Erfindung betrifft weiterhin (2) DNA-Sequenzen, die für die vorstehenden in (1) definierten Desaturasen kodieren, wobei die in Fig. 15 gezeigte DNA-Sequenz nicht mit eingeschlossen ist. Die DNA-Sequenz ist dabei bevorzugt aus aus Arabidopsis thaliana und Brassica napus erhältlich, wobei DNA-Sequenzen, die die in Fig. 1 oder 3 gezeigten Sequenzen umfassen, besonders bevorzugt sind.The invention further relates to (2) DNA sequences which code for the above desaturases defined in (1), the DNA sequence shown in FIG. 15 not being included. The DNA sequence is preferably obtainable from Arabidopsis thaliana and Brassica napus, with DNA sequences comprising the sequences shown in FIG. 1 or 3 being particularly preferred.
Weiterhin werden (3) Vektoren, die die in (2) definierte DNA-Sequenzen umfassen, offenbart. Die erfindungsgemäßen Vektoren können zusätzlich zu den DNA- Sequenzen noch die Expression dieser DNA-Sequenzen fördernde funktioneile DNA-Sequenzen wie z. B. Promotoren, ein Terminationssignal und/oder Sekretionssequenzen enthalten, die mit den DNA-Sequenzen (2) funktioneil verknüpft sind.Furthermore, (3) vectors comprising the DNA sequences defined in (2) are disclosed. The vectors according to the invention can be used in addition to the DNA Sequences still functional DNA sequences promoting the expression of these DNA sequences such. B. promoters, a termination signal and / or secretion sequences that are functionally linked to the DNA sequences (2).
Weiterhin betrifft die ErfindungThe invention further relates to
(4) Zellen, die mit einem der in (3) definierten Vektoren transformiert sind, wobei diese Zellen vorzugsweise Pflanzen-, Pilz-, Bakterien- oder Tierzellen sind;(4) cells transformed with one of the vectors defined in (3), these cells preferably being plant, fungal, bacterial or animal cells;
(5) transgene Organismen, die a) eine DNA-Sequenz, wie vorstehend unter (2) definiert, umfassen b) einen Vektor, wie vorstehend unter (3) definiert, umfassen und/oder c) aus einer Zelle, wie vorstehend unter (4) definiert, generierbar sind;(5) transgenic organisms which comprise a) a DNA sequence as defined above under (2), b) a vector as defined above under (3) and / or c) from a cell as above under ( 4) defined, can be generated;
(6) Pflanzen oder deren Nachkommschaft, die aus der Pflanzenzelle, wie vorstehend unter (5) definiert, generierbar sind, wobei die Pflanzen bevorzugt Nutzpflanzen sind und/oder ein verändertes delta-8-Basenmuster aufweisen; und(6) plants or their progeny which can be generated from the plant cell as defined under (5) above, the plants preferably being useful plants and / or having a modified delta-8 base pattern; and
(7) ein Verfahren zur Herstellung von Pflanzen die einen erhöhten oder reduzierten Anteil oder ein verändertes cis/trans-Verhältnis an delta-8-ungesättigten langkettigen Basen aufweist, umfassend a) die Transformation einer Pflanzenzelle mit einer DNA-Sequenz, wie vorstehend unter (2) definiert, einschließlich der DNA Sequenzen aus Fig. 15, und b) die Regeneration einer Pflanze mit verändertem delta-8-Basenmuster in ihren Sphingolipiden.(7) a process for the production of plants which has an increased or reduced proportion or a modified cis / trans ratio of delta-8-unsaturated long-chain bases, comprising a) transforming a plant cell with a DNA sequence, as described above under ( 2), including the DNA sequences from FIG. 15, and b) the regeneration of a plant with an altered delta-8 base pattern in its sphingolipids.
Das Verfahren gemäß (7) ist dabei a) zum Kompensieren eines Mangels an delta-8-ungesättigten langkettigen Basen in einem Organismus b) zum Ausschalten der Produktion an delta-8-ungesättigten Basen, c) zur Herstellung von Pflanzen mit verbesserter Toleranz und Resistenz gegenüber Bodenversalzung und/oder lonenstress bzw. -toxizität und /oder Trockenheit und/oder Feuchte und /oder Kälte bzw. Frost und pflanzenpathogenen Mikroorganismen und d) zur Herstellung von Pflanzen mit geändertem Größenwachstum und Blütezeit geeignet. Zur Herstellung transgener Pflanzen mit einem stark reduziertem Gehalt an deIta-8- ungesättigten langkettigen Basen in ihren Sphingolipiden kann z. B. das o.g. Gen aus A. thaliana in antisense-Orientierung und das o.g. Gen aus B. napus in sense- Orientierung (Co-Supression) in einen konstitutiven Pflanzen-Expressionsvektor kloniert werden. Die Transformation von A. thaliana erfolgt dann z. B. mit Hilfe der Agrobacterium fcvme ac/ens-vermittelten in planta Vakuum-Infiltration (N. Bechthold et al., „In Planta Agrobacterium mediated gene transfer by infiltratio of adult Arabidopsis thaliana plants", C. R. Acad. Sei., Paris, Life Science 316: 1194-1199 (1993); A. F. Bent et al., „RPS2 of Arabidopsis thaliana: A Leucine-Rich Repeat Class of Plant Disease Resistance Genes", Science 265: 1856-1860 (1994)). Die erfolgreiche Suppression der delta-8-Sphingolipid-Desaturierung kann in den transgenen Pflanzen durch die Analyse der langkettigen Basen, die aus den Sphingolipiden isoliert werden, nachgewiesen werden.The method according to (7) is a) to compensate for a lack of delta-8-unsaturated long-chain bases in an organism b) to switch off the production of delta-8-unsaturated bases, c) to produce plants with improved tolerance and resistance against salinization and / or ionic stress or toxicity and / or drought and / or moisture and / or cold or frost and plant pathogenic microorganisms and d) suitable for the production of plants with changed size growth and flowering time. For the production of transgenic plants with a greatly reduced content of deIta-8 unsaturated long-chain bases in their sphingolipids, e.g. B. the above-mentioned gene from A. thaliana in antisense orientation and the above-mentioned gene from B. napus in sense orientation (co-suppression) can be cloned into a constitutive plant expression vector. The transformation of A. thaliana then takes place e.g. B. with the help of Agrobacterium fcvme ac / ens-mediated in planta vacuum infiltration (N. Bechthold et al., "In Planta Agrobacterium mediated gene transfer by infiltration of adult Arabidopsis thaliana plants", CR Acad. Sei., Paris, Life Science 316: 1194-1199 (1993); AF Bent et al., "RPS2 of Arabidopsis thaliana: A Leucine-Rich Repeat Class of Plant Disease Resistance Genes", Science 265: 1856-1860 (1994)). Successful suppression of delta-8 sphingolipid desaturation can be demonstrated in the transgenic plants by analyzing the long-chain bases isolated from the sphingolipids.
Weiterhin betrifft die ErfindungThe invention further relates to
(8) ein Verfahren zur Herstellung von Sphingolipiden und von Capnoiden mit ungesättigten Sphingobase, umfassend das Kultivieren von Zellen, Organismen oder Pflanzen, wie vorstehend unter (4) - (6) definiert. Das Verfahren umfaßt weiterhin die Isolierung der Sphingolipide aus der Kultur. Das hergestellte Sphingolipid ist dabei vorzugsweise eine Verbindung mit der Formel (I)(8) a method for producing sphingolipids and capnoids with unsaturated sphingobase, comprising culturing cells, organisms or plants as defined in (4) - (6) above. The method further includes isolating the sphingolipids from the culture. The sphingolipid produced is preferably a compound of the formula (I)
Figure imgf000008_0001
Figure imgf000008_0001
worinwherein
R1 -OH, -OPO3HR6, ein Kohlenhydratrest oder -S03H ist;R 1 is -OH, -OPO 3 HR 6 , a carbohydrate residue or -S0 3 H;
R2 ein d-C33-Alkylrest ist, der ein- oder mehrfach ungesättigt und/oder mit einem oder mehreren Hydroxylresten substituiert sein kann;R 2 is a dC 33 alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more hydroxyl radicals;
R3 und R5 unabhängig voneinander -H oder -OH sind, oder R3 und R5 zusammen eine trans-Doppelbindung bilden; R4 -H oder ein C-ι-C15-Alkylrest ist, der ein- oder mehrfach ungesättigt und/oder mit einem oder mehreren Methylresten substituiert sein kann; Rδ -H, ein Polyhydroxyalkylrest, ein Aminoalkylrest oder ein Kohlenhydratrest ist; und entweder a, b oder c eine Doppelbindung ist, wobei,R 3 and R 5 are independently -H or -OH, or R 3 and R 5 together form a trans double bond; R 4 is -H or a C 1 -C 15 -alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more methyl radicals; R δ is -H, a polyhydroxyalkyl group, an aminoalkyl group or a carbohydrate group; and either a, b or c is a double bond,
(a) wenn R3 und R5 -H sind, a eine Doppelbindung ist, und(a) when R 3 and R 5 are -H, a is a double bond, and
(b) wenn R3 -OH ist und R5 -H ist, a oder b eine Doppelbindung ist.(b) when R 3 is -OH and R 5 is -H, a or b is a double bond.
In den hergestellten Sphingolipiden ist vorzugsweise R2 ein Cιo-C2 -Alkylrest und R4 ein C3-Ci2-Alkylrest, insbesondere ein C7-, Cg- oder Cn-Alkylrest. Ein Kohlenhydratrest im Sinne der vorliegenden Erfindung besteht aus einer oder mehreren glycosidisch verknüpften Aldopentosen, Aldohexosen, Ketohexosen sowie den daraus abgeleiteten Amino-, Uron- und Desoxyderivaten. Unter Polyhydroxyverbindungen sind von Alkanpolyolen wie Glycol, Glycerin und Mannit abgeleiteten Reste zu verstehen. Aminoalkylreste im Sinne der vorliegenden Erfindung sind 2-Aminoethyl- und 2-(Trimethylammonium)alkylreste. Insbesondere ist das hergestellte Sphingolipid eine Verbindung mit der Formel (II)In the sphingolipids produced, R 2 is preferably a C 1 -C 2 -alkyl radical and R 4 is a C 3 -Ci2-alkyl radical, in particular a C 7 -, Cg- or Cn-alkyl radical. A carbohydrate residue in the sense of the present invention consists of one or more glycosidically linked aldopentoses, aldohexoses, ketohexoses and the amino, urone and deoxy derivatives derived therefrom. Polyhydroxy compounds are to be understood as radicals derived from alkane polyols such as glycol, glycerol and mannitol. Aminoalkyl radicals for the purposes of the present invention are 2-aminoethyl and 2- (trimethylammonium) alkyl radicals. In particular, the sphingolipid produced is a compound of the formula (II)
Figure imgf000009_0001
Figure imgf000009_0001
worin R1, R2, R3, a und b die oben angegebene Bedeutung aufweisen.wherein R 1 , R 2 , R 3 , a and b have the meaning given above.
Bei der erfindungsgemäßen Klonierung und Expression des für eine Sphingolipid- Desaturase codierenden Gens s/ /1 aus cDNA der Pflanzen Arabidopsis thaliana und Brassica napus in der Hefe Saccharomyces konnten neuartiger Produkte in den transgenen Hefen nachgewiesen werden, deren chemische Struktur eindeutig identifiziert wurde. Es handelt sich um verschiedene Sphingolipide deren Spingobasen unterschiedliche Regio- und Stereoisomerie der Doppelbindung aufweisen: (i) D-eryf 7ro-2-Amino-1 ,3,4-trihydroxy-(8Z)-octadecen (t18:18öcλ )In the cloning and expression according to the invention of the gene s / / 1 coding for a sphingolipid desaturase from cDNA of the plants Arabidopsis thaliana and Brassica napus in the yeast Saccharomyces, novel products could be detected in the transgenic yeasts, the chemical structure of which was clearly identified. These are different sphingolipids whose spingobases have different regio- and stereoisomerism of the double bond: (i) D-eryf 7ro-2-amino-1, 3,4-trihydroxy- (8Z) -octadecene (t18: 18 ö c λ )
(ii) D-etyf/Vo-2-Amino-1 ,3,4-trihydroxy-(8E)-octadecen
Figure imgf000010_0001
(ii) D-etyf / Vo-2-amino-1, 3,4-trihydroxy- (8E) octadecene
Figure imgf000010_0001
9cx9cx
D-etyf/7ro-2-Amino-1 ,3,4-trihydroxy-(9Z)-octadecen (t18: 1 ao) (iv) D-e/yf 7ro-2-Amino-1 ,3,4-trihydroxy-(9E)-octadecen (t18:19t)D-etyf / 7ro-2-amino-1, 3,4-trihydroxy- (9Z) -octadecene (t18: 1 ao ) (iv) De / yf 7ro-2-amino-1, 3,4-trihydroxy- ( 9E) octadecene (t18: 1 9t )
Überraschenderweise wurden in den transgenen Hefen nicht nur die pflanzentypischen delta-8 Stereoisomere (i) und (ii), wie sie z. B. aus H. Imai et al., „Sphingoid Base Composition of Cerebrosides from Plant Leaves", Biosci. Biotech. Biochem. 61: 351-353 (1997), bekannt sind, sondern auch das in der Natur nicht vorkommende delta-9 Regioisomer (iii) und (iv) des Phytosphingenins gebildet.Surprisingly, not only the plant-typical delta-8 stereoisomers (i) and (ii), as described, for. B. from H. Imai et al., "Sphingoid Base Composition of Cerebrosides from Plant Leaves", Biosci. Biotech. Biochem. 61: 351-353 (1997), but also delta-9, which does not occur in nature Regioisomer (iii) and (iv) of the phytosphinine formed.
Die Erfindung betriff somit auch (9) Spingobasen und Capnoide mit ungesättigter Sphingobase mit der FormelThe invention thus also relates to (9) spingobases and capnoids with unsaturated sphingobase with the formula
Figure imgf000010_0002
Figure imgf000010_0002
(D.(D.
worinwherein
R1 -OH, -OPO3HR6, ein Kohlenhydratrest oder -S03H ist;R 1 is -OH, -OPO 3 HR 6 , a carbohydrate residue or -S0 3 H;
R2 ein Cι-C33-Alkylrest ist, der ein- oder mehrfach ungesättigt und/oder mit einem oder mehreren Hydroxylresten substituiert sein kann;R 2 is a -CC 33 alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more hydroxyl radicals;
R3 und R5 unabhängig voneinander -H oder -OH sind, oder R3 und R5 zusammen eine trans-Doppelbindung bilden;R 3 and R 5 are independently -H or -OH, or R 3 and R 5 together form a trans double bond;
R4 -H oder ein C-i-Cis-Alkylrest ist, der ein- oder mehrfach ungesättigt und/oder mit einem oder mehreren Methylresten substituiert sein kann;R 4 is -H or a Ci-Cis-alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more methyl radicals;
R6 -H, ein Polyhydroxyalkylrest, ein Aminoalkylrest oder ein Kohlenhydratrest ist; und entweder a, b oder c eine Doppelbindung ist, wobei,R 6 is -H, a polyhydroxyalkyl group, an aminoalkyl group or a carbohydrate group; and either a, b or c is a double bond,
(a) wenn R3 und R5 -H sind, a eine Doppelbindung ist, (b)wenn R3 -OH ist und R5 -H ist, a oder b eine Doppelbindung ist, und (b) wenn R4 ein C7-, C9- oder Cn-Alkylrest ist, a keine Doppelbindung ist, und Derivate derselben.(a) when R 3 and R 5 are -H, a is a double bond, (b) when R 3 is -OH and R 5 is -H, a or b is a double bond, and (b) when R 4 is a C 7 -, C 9 - or Cn-alkyl radical, a is not a double bond, and Derivatives of the same.
Bevorzugte Ausführungsformen sind vorstehend unter (8) erwähnt. Unter „Derivate" sind Produkte aus chemischen oder enzymatischen Umsetzungen zu verstehen, wobei durch diese Umsetzung das Molgewicht der Sphingobase sowohl erhöht (z. B. durch O-Acylierung und Hydroxylierung von Doppelbindungen) als auch durch Spaltungsreationen verringert sein kann (z. B. durch Abspaltung des Fettsäurerests des Ceramid rests). Unter „Derivat" ist somit auch die freie Sphingobase zu verstehen.Preferred embodiments are mentioned above under (8). “Derivatives” are to be understood as products from chemical or enzymatic reactions, with this reaction the molecular weight of the sphingobase can both be increased (eg by O-acylation and hydroxylation of double bonds) and reduced by cleavage reactions (eg by splitting off the fatty acid residue of the ceramide residue). “Derivative” is therefore also to be understood as the free sphingobase.
Bevorzugt Sphingolipide sind solche mit der nachfolgenden Formel:Sphingolipids with the following formula are preferred:
Figure imgf000011_0001
Figure imgf000011_0001
(Hl).(St.).
wobei R1, R2, R3, R4, R5, b und c die oben angegebene Bedeutung haben.wherein R 1 , R 2 , R 3 , R 4 , R 5 , b and c have the meaning given above.
Schließlich betrifft die Erfindung (10) Kosmetika, Arznei- oder Nahrungsmittel oder chemische Rohstoffe, die eine Verbindung, wie gemäß dem Verfahren (8) hergestellt oder wie in (9) definiert, umfassen. Unter Arzneimittel sind dabei Mittel zur Regulation des Blutdrucks und Herzrythmus, zur Modulation der Insulinsekretion, Mittel zur Wundheilung, Mittel mit Anti-Tumor-Aktivität, Schutzwirkung gegen Radioaktivität, Stimulation des Zellwachstums, Beeinflußung der Leukozytendifferenzierung, Immunrezeptoren für Viren, bakterielle und Mycotoxine. Die zahlreichen humanen Sphingolipid-Speicherkrankheiten, wie z. B. Niemann-Pick- und Tay-Sachs-Disease, legen ebenfalls eine Anwendung als therapeutisch wirksame Feinchemikalie beim Menschen nahe, mit einem hohen pharmacologischen, toxicologischen und Ernährungspotential.Finally, the invention relates to (10) cosmetics, pharmaceuticals or foodstuffs or chemical raw materials which comprise a compound as produced according to method (8) or as defined in (9). Medicines include agents for regulating blood pressure and heart rhythm, for modulating insulin secretion, agents for wound healing, agents with anti-tumor activity, protective action against radioactivity, stimulation of cell growth, influencing leukocyte differentiation, immunoreceptors for viruses, bacterial and mycotoxins. The numerous human sphingolipid storage diseases, such as. B. Niemann-Pick and Tay-Sachs disease, also put an application as therapeutic effective fine chemical close to humans, with a high pharmacological, toxicological and nutritional potential.
Weitere Möglichkeiten diese Substanzen wirtschaftlich zu nutzen bestehen darin, deren Gehalt und/oder Zusammensetzung in bestimmten Organismen zu manipulieren und damit ökonomisch relevante Eigenschaften dieser Organismen positiv zu verändern. Marktchancen sehen wir im Bereich von Veränderungen hinsichtlich des Wachstumsverhalten (Längenzuwachs und Blattspreitengröße) sowie der Beeinflußung des Blühbeginns bei transgenen Nutzpflanzen. Durch eine heterologe Expression und/oder homologe Überexpression und/oder antisense- Ausschaltung der Sphingolipid-Desaturase Gene könnten Kulturpflanzen mit verbesserter Toleranz oder Resistenz 1.) gegenüber schädlichen Umwelteinflüssen wie Bodenversalzung, lonenstress und -toxizität, Trockenheit, Feuchte und Kälte/Frost (M. Uemura et.al., „Cold Acciimation of Arabidopsis thaliana", Plant Physiol. 109: 15-30 (1995) bzw. 2.) gegenüber pflanzenpathogenen Mikroorganismen (z.B. Pilzresistenz) erzeugt werden. Die meisten kühleresistenten Pflanzen zeichnen sich durch einen höheren Anteil an delta-8-c/s-Phytosphingenin aus (H. Imai et al., s. o.). Weiterhin ist gezeigt worden, daß planzliche und pilzeigene Cerebroside mit delta-8-ungesättigten langkettigen Basen die Fruchtkörperbildung von Pilzen induzieren bzw. steigern können (Kawai et al., „Stimulatory effect of certain plant sphingolipids on fruiting of Schyzophyllum commune", J. Biol. Chem. 261: 779-784 (1986)).Further possibilities to use these substances economically are to manipulate their content and / or composition in certain organisms and thus to change the economically relevant properties of these organisms positively. We see market opportunities in the area of changes with regard to growth behavior (length increase and leaf blade size) as well as influencing the start of flowering in transgenic crop plants. Heterologous expression and / or homologous overexpression and / or antisense elimination of the sphingolipid desaturase genes could result in crop plants with improved tolerance or resistance 1.) to harmful environmental influences such as soil salinity, ion stress and toxicity, dryness, moisture and cold / frost (M . Uemura et.al., "Cold Accimation of Arabidopsis thaliana", Plant Physiol. 109: 15-30 (1995) or 2.) against plant-pathogenic microorganisms (for example fungus resistance). Most plants which are resistant to coolers are distinguished by a higher one Proportion of delta-8-c / s-phytosphingenin from (H. Imai et al., See above) Furthermore, it has been shown that vegetable and fungal cerebrosides with delta-8-unsaturated long-chain bases can induce or increase the fruiting of mushrooms (Kawai et al., "Stimulatory effect of certain plant sphingolipids on fruiting of Schyzophyllum commune", J. Biol. Chem. 261: 779-784 (1986)).
Durch eine Antisense-Ausschaltung des entsprechenden Δ6-Sphingolipid- Desaturasegens in Mikroorganismen, wie z. B. Hefen und Pilze, könnte deren Phyto- und/oder Humanpathogenität vermindert werden. Durch eine heterologe Expression der pflanzlichen Sphingolipid-Desaturase in Mikroorganismen wie z. B. Bäcker-, Brauhefe und deren Mutanten (R. C. Dickson et al., „Isolation of mutant Saccharomyces cerevisiae strains that survive without sphingolipids", Mol. Cell Biol. 10: 2176-2181 (1990); W. J. Pinto et al., „Characterization of Enzymatic Synthesis of Sphingolipid Long-Chain Bases in Saccharomyces cerevisiae: Mutant Strains Exhibiting Long-Chain-Base Auxotrophy Are Deficient in Serine palmitoyltransferase Activity", J. Bacteriol. 174: 2575-2581 (1992)) könnten diese in ihren Wachstumseigenschaften, z. B. Temperaturtoleranz, verbessert werden und als Bioreaktoren für natürliche und artifizielle Spingolipide und deren Folgeprodukte dienen.By antisense switching off the corresponding Δ6-sphingolipid desaturase gene in microorganisms, such as. B. yeasts and fungi, their phyto- and / or human pathogenicity could be reduced. By heterologous expression of the plant sphingolipid desaturase in microorganisms such as. B. Baker's, brewer's yeast and their mutants (RC Dickson et al., "Isolation of mutant Saccharomyces cerevisiae strains that survive without sphingolipids", Mol. Cell Biol. 10: 2176-2181 (1990); WJ Pinto et al., " Characterization of Enzymatic Synthesis of Sphingolipid Long-Chain Bases in Saccharomyces cerevisiae: Mutant Strains Exhibiting Long-Chain-Base Auxotrophy Are Deficient in Serine palmitoyltransferase Activity ", J. Bacteriol. 174: 2575-2581 (1992)) could include these in their Growth properties, e.g. B. temperature tolerance, be improved and serve as bioreactors for natural and artificial spingolipids and their derivatives.
Eine Expression der pflanzlichen Sphingolipid-Desaturase kann auch in Prokaryoten zu modifizierten Sulfonolipiden und Folgeprodukten führen, die einerseits deren Beweglichkeit verändern und andererseits als neue chemische Verbindungen wirtschaftlich interessant sein könnten.Expression of the plant sphingolipid desaturase can also lead to modified sulfonolipids and derived products in prokaryotes, which on the one hand change their mobility and on the other hand could be economically interesting as new chemical compounds.
Die Erfindung wird anhand der folgenden Figuren und Beispiele näher erläutert.The invention is illustrated by the following figures and examples.
FigurenbeschreibungFigure description
Fig. 1 : Nukleotidsequenz (1594 bp) der Sphingolipid-Desaturase (s/ 1) aus Brassica napus mit 5'- und 3'-untranslatierten Regionen und offenem Leseraster.1: Nucleotide sequence (1594 bp) of the sphingolipid desaturase (s / 1) from Brassica napus with 5'- and 3'-untranslated regions and an open reading frame.
Fig. 2: Deduzierte Aminosäuresequenz (449 aa) der Sphingolipid-Desaturase aus ß. napus.Fig. 2: Reduced amino acid sequence (449 aa) of the sphingolipid desaturase from β. napus.
Fig. 3: Nukleotidsequenz (1678 bp) der Sphingolipid-Desaturase (s/cf1) aus Arabidopsis thaliana mit 5'- und 3'-untranslatierten Regionen und offenem Leseraster.3: Nucleotide sequence (1678 bp) of the sphingolipid desaturase (s / cf1) from Arabidopsis thaliana with 5'- and 3'-untranslated regions and an open reading frame.
Fig. 4: Deduzierte Aminosäuresequenz (449 aa) der Sphingolipid-Desaturase aus A. thaliana.Fig. 4: Reduced amino acid sequence (449 aa) of the sphingolipid desaturase from A. thaliana.
Fig. 5: Proteinsequenzvergleiche der Sphingoiipid-Desaturasen aus ß. napus (BnDESδ, Fig. 2), A. thaliana (AtDES8, Fig. 4) und Sonnenblume (HaDES?, (Sperling et al., 1995), Fig. 15) mit der delta-6 Glycerolipid-Desaturase aus Borretsch (B0DES6 (Sayanova et al., 1997)). Die N-terminale Domäne bis Position 121 der Sonnenblumensequenz ist mit dem hydrophilen Teil von Cytochrome b5 homolog, dessen konservierte Aminosäuren unterstrichen sind. Die drei hoch konservierten Histidinboxen (Shanklin et al., 1994), die charakteristisch für Lipid-Desaturasen sind, sind eingezeichnet. Identische Aminosäuren sind durch graue Schattierung hervorgehoben.Fig. 5: Protein sequence comparisons of the Sphingoiipid desaturases from β. napus (BnDESδ, Fig. 2), A. thaliana (AtDES8, Fig. 4) and sunflower (HaDES ?, (Sperling et al., 1995), Fig. 15) with the delta-6 glycerolipid desaturase from Borage (B0DES6 (Sayanova et al., 1997)). The N-terminal domain up to position 121 of the sunflower sequence is homologous to the hydrophilic part of cytochrome b 5 , the conserved amino acids of which are underlined. The three highly conserved histidine boxes (Shanklin et al., 1994), which are characteristic of lipid desaturases, are shown. Identical amino acids are highlighted by gray shading.
Fig. 6: Vektorkonstrukt zur Expression des s/crt -Gens aus ß. napus (pYES2Bn) in der Hefe Saccharomyces cerevisiae.6: Vector construct for the expression of the s / crt gene from β. napus (pYES2Bn) in the yeast Saccharomyces cerevisiae.
Fig. 7: Vektorkonstrukt zur Expression des s/cd -Gens aus A. thaliana (pYES2At) in der Hefe Saccharomyces cerevisiae.7: Vector construct for the expression of the s / cd gene from A. thaliana (pYES2At) in the yeast Saccharomyces cerevisiae.
Fig. 8: Bildung von Phytosphingeninen in Hefezellen durch heterologe Expression pflanzlicher Sphingoiipid-Desaturasen. Die langkettigen Basen (LCB) der Sphingolipide wurden aus ganzen Zellen durch starke alkalische Hydrolyse (Morrison und Hay, 1970) gewonnen, in ihre Dinitrophenyl-Derivate (Karisson, 1970) überführt und mittels RP-HPLC analysiert. (A) Trennung der Referenzsubstanzen (Sigma) Phytosphinganin (t18:0), 4-rrans-Sphingenin (d18:1) und Sphinganine (d18:0). (B) LCB-Muster der Wildtyp-Hefezellen (INVSd) bzw. transformiert mit dem Leervektor pYES2. Bildung von eis- und frans-Phytosphingenin (t18:1) in Hefezellen, die entweder (C) das A.thaliana Fusionsprotein (pYES2At) oder (D) das ß. napus Fusionsprotein (pYES2Bn) exprimieren. (E) LCB-Muster von A. thaliana (Wildtyp) - Pflanzen.Fig. 8: Formation of phytosphine genes in yeast cells by heterologous expression of plant sphingoiipid desaturases. The long-chain bases (LCB) of the sphingolipids were obtained from whole cells by strong alkaline hydrolysis (Morrison and Hay, 1970), converted into their dinitrophenyl derivatives (Karisson, 1970) and analyzed by RP-HPLC. (A) Separation of the reference substances (Sigma) phytosphinganine (t18: 0), 4-rrans-sphingenine (d18: 1) and sphinganine (d18: 0). (B) LCB pattern of the wild-type yeast cells (INVSd) or transformed with the empty vector pYES2. Formation of eis- and frans-phytosphingenin (t18: 1) in yeast cells which contain either (C) the A.thaliana fusion protein (pYES2At) or (D) the ß. express napus fusion protein (pYES2Bn). (E) LCB pattern of A. thaliana (wild type) plants.
Fig. 9: GC-MS Elutionsprofil von Fettsäuremethylestern, die durch KMn0 -Oxidation eines ungesättigten Phytosphinganin-Isomerengemischs erhalten werden (Beispiel 5).9: GC-MS elution profile of fatty acid methyl esters which are obtained by KMn0 oxidation of an unsaturated phytosphinganine isomer mixture (Example 5).
Fig. 10: Partielle 1H-NMR-Spektren (600 MHz) von (A) trans-Δ8'9- und (B) cis-Δ8'9- Phytosphingenin. Die Zuordnung der Signale erfolgte mittels COSY Experimenten.Fig. 10: Partial 1 H-NMR spectra (600 MHz) of (A) trans-Δ 8 ' 9 - and (B) cis-Δ 8 ' 9 - phytosphingenin. The signals were assigned using COZY experiments.
Fig. 11 : Vektorkonstrukt zur heterologen Überexpression in Sense-Orientierung des s/c/1-Gens aus ß. napus (pBIB5Bn) in A. thaliana.11: Vector construct for heterologous overexpression in sense orientation of the s / c / 1 gene from β. napus (pBIB5Bn) in A. thaliana.
Fig. 12: Vektorkonstrukt zur homologen Antisense-Suppression des s/c 1-Gens aus A. thaliana (pBIB5At) in A. thaliana. Fig. 13: Suppression der delta-8-Sphingolipid-Desaturierung in transgenen A. thaliana-P anzen. Die langkettigen Basen (LCB) der Sphingolipide wurden aus Mischproben (350 mg Frischgewicht) ganzer T2-Pflanzen, 34 d nach Keimung, durch starke alkalische Hydrolyse (Morrison und Hay, 1970) gewonnen, in ihre Dinitrophenyl-Derivate (Karisson, 1970) überführt und mittels RP-HPLC analysiert. (A) Trennung der Referenzsubstanzen (Sigma) Phytosphinganin (t18:0), 4-trans- Sphingenin (d18:1) und Sphinganine (d18:0). (B) LBC-Muster der Wildtyp-Pflanzen bzw. transformiert mit dem Leervektor pBI121. Reduktion von eis- und trans-A8- Phytosphingenin (t18:1) in T2-Pflanzen (C) durch homologe Antisense-Expression des s/cd -Gens aus A. thaliana (pBIB5At) und (D) durch heterologe Sense- Expression (Co-Suppression) des s/c/1-Gens aus ß. napus (pBIB5Bn).Fig. 12: Vector construct for homologous antisense suppression of the s / c 1 gene from A. thaliana (pBIB5At) in A. thaliana. Fig. 13: Suppression of delta-8 sphingolipid desaturation in transgenic A. thaliana plants. The long-chain bases (LCB) of the sphingolipids were obtained from mixed samples (350 mg fresh weight) of whole T2 plants, 34 d after germination, by strong alkaline hydrolysis (Morrison and Hay, 1970) and converted into their dinitrophenyl derivatives (Karisson, 1970) and analyzed by RP-HPLC. (A) Separation of the reference substances (Sigma) phytosphinganine (t18: 0), 4-trans-sphingenine (d18: 1) and sphinganine (d18: 0). (B) LBC pattern of the wild-type plants or transformed with the empty vector pBI121. Reduction of ice and trans-A8 phytosphingenin (t18: 1) in T2 plants (C) by homologous antisense expression of the s / cd gene from A. thaliana (pBIB5At) and (D) by heterologous sense expression ( Co-suppression) of the s / c / 1 gene from ß. napus (pBIB5Bn).
Fig. 14: Regioselektivität der pflanzlichen Sphingolipid-Desaturase. Die Δ-6- Sphingolipid-Desaturasen führen eine delta-8- und -9-Doppelbindung in eis- und frans-Konfiguration in langkettige Basen ein, was zur Bildung von Phytosphingenin bzw. phytosphingininhaltiger Sphingolipide (t18:1) in den transformierten Hefezellen führt (R repräsentiert eine Vielzahl möglicher Fettsäurereste).Fig. 14: Regioselectivity of the plant sphingolipid desaturase. The Δ-6-sphingolipid desaturases introduce a delta-8 and -9 double bond in the eis and frans configuration into long-chain bases, which leads to the formation of phytosphingenin or phytosphinginin-containing sphingolipids (t18: 1) in the transformed yeast cells (R represents a variety of possible fatty acid residues).
Fig. 15: Nukleotid- und davon abgeleitete Aminosäuresequenz aus P. Sperling et al. (1995), s. o.15: nucleotide and amino acid sequence derived therefrom from P. Sperling et al. (1995), p. O.
Fig. 16: Erweiterter Proteinsequenzvergleich von Sphingoiipid-Desaturasen (die oberen 5 Sequenzen) mit Δ6-Fettsäuredesaturasen (BnDES8, AtDES8, HaDES? Und B0DES6 s. Fig. δ; dδlpu, bδlbo und dδ2pu sind unveröffentlichte Teilsequenzen der Anmelderin; bδcae, 2bδce und bδpp haben die EMBC Accession Numbers Z70271 , Z81122 und AJ222980).Fig. 16: Extended protein sequence comparison of sphingoiipid desaturases (the top 5 sequences) with Δ6 fatty acid desaturases (BnDES8, AtDES8, HaDES? And B0DES6 see Fig. Δ; dδlpu, bδlbo and dδ2pu are unpublished partial sequences of the applicant, 2bδca bδpp have the EMBC Accession Numbers Z70271, Z81122 and AJ222980).
BeispieleExamples
Nachfolgend werden folgende Abkürzungen verwendet: cDNA copy-Desoxyribonukleinsäure FAME FettsäuremethylesterThe following abbreviations are used: cDNA copy-deoxyribonucleic acid FAME fatty acid methyl ester
GC-MS Gaschromatographie-MassenspektroskopieGC-MS gas chromatography mass spectrometry
HPLC Hochdruck-FlüssigkeitschromatographieHPLC high pressure liquid chromatography
LCB langkettige Basen (der Sphingolipide) mRNA Boten-RibonukleinsäureLCB long chain bases (of the sphingolipids) mRNA messenger ribonucleic acid
NMR 'Nuclear Magnetic Resonance' SpektroskopieNMR 'Nuclear Magnetic Resonance' spectroscopy
PCR PolymerasekettenreaktionPCR polymerase chain reaction
TLC DünnschichtchromatographieTLC thin layer chromatography
Beispiel 1 : Isolierung und Klonierung von S/Q*1 aus B.napusExample 1: Isolation and cloning of S / Q * 1 from B.napus
Restriktionsendonukleasen und DNA modifizierende Enzyme wurden, wenn nicht anders angegeben von den Firmen New England Biolabs und Boehringer Mannheim bezogen und nach Angaben des Herstellers verwendet. E. coli XL1 blue, MRF' (Stratagene) wurde bei 37 °C in LB-Medium (J. Sambrook et al., „Molecular Cloning: A Laboratory Manual", 2nd edn., Cold Spring Harbor Laboratory Press, USA (19δ9)) angezogen. Für die Selektion von mit Plasmiden transformierten E. colis wurden die Antibiotika Ampicillin (100 μg/ml) und Kanamycin (30 μg/ml) dem Medium zugesetzt. Die Transformation kompetenter E. coli erfolgte nach H. Inoue et al., „High efficiency transformation of Escherichia coli with plasmids", Gene 96: 23-2δ(1990) und die DNA-Minipräparation nach M. G. Riggs et al., „A simplified screening procedure for large numbers of plasmid mini-preparation", BioTechniques 4: 310-313 (19δ6).Unless otherwise stated, restriction endonucleases and DNA-modifying enzymes were obtained from New England Biolabs and Boehringer Mannheim and used according to the manufacturer's instructions. E. coli XL1 blue, MRF '(Stratagene) was at 37 ° C in LB medium (J. Sambrook et al., "Molecular Cloning: A Laboratory Manual", 2nd edn., Cold Spring Harbor Laboratory Press, USA (19δ9 For the selection of E. colis transformed with plasmids, the antibiotics ampicillin (100 μg / ml) and kanamycin (30 μg / ml) were added to the medium, and competent E. coli were transformed according to H. Inoue et al. , "High efficiency transformation of Escherichia coli with plasmids", Gene 96: 23-2δ (1990) and the DNA mini-preparation according to MG Riggs et al., "A simplified screening procedure for large numbers of plasmid mini-preparation", BioTechniques 4 : 310-313 (19δ6).
Um eine homologe DNA-Sequenz aus Brassica napus zu isolieren, wurden degenerierte Oligonucleotideprimer von der funktional unbekannten DNA-Sequenz aus Helianthus annuus (Sperling et al. (199δ), s.o.) abgeleitet. Ein δ71 bp langes DNA-Fragmentes wurde aus einer lambda-ZAP cDNA-Bank aus reifenden Schoten von Brassica napus cv. Ascari (M. Fulda et al.," Brassica napus cDNAs encoding fatty acyl-CoA synthetase", Plant Mol. Biol. 33: 911-922 (1997)) mittels PCR (Polymerasekettenreaction) isoliert. Hierzu wurden die degenerierten PrimerIn order to isolate a homologous DNA sequence from Brassica napus, degenerate oligonucleotide primers were derived from the functionally unknown DNA sequence from Helianthus annuus (Sperling et al. (199δ), see above). A δ71 bp long DNA fragment was extracted from a lambda-ZAP cDNA library from maturing pods of Brassica napus cv. Ascari (M. Fulda et al., "Brassica napus cDNAs encoding fatty acyl-CoA synthetase", Plant Mol. Biol. 33: 911-922 (1997)) was isolated by means of PCR (polymerase chain reaction). For this, the degenerate primers were used
BN1 (δ'-G[GC][ATGC]TGGTGGAA[AG]TGG-3') und BN2 (δ'-GG[AG]AA[ATGC]A[AG][AG]TG[AG]TG-3') eingesetzt, die den Aminosäuresequenzen [GA] WWKW und HHLFP aus H.annuus entsprechen.BN1 (δ'-G [GC] [ATGC] TGGTGGAA [AG] TGG-3 ') and BN2 (δ'-GG [AG] AA [ATGC] A [AG] [AG] TG [AG] TG-3' ) used, which correspond to the amino acid sequences [GA] WWKW and HHLFP from H.annuus.
Es wurde folgendes Programm für die Amplifizierung benutzt: δ min bei 96 °C, gefolgt von 30 Zyklen von 20 s bei 96 °C, 1 min bei 40 °C (Bindungstemperatur, Tm) und 2 min bei 72 °C, 1 Zyklus von 10 min bei 72 °C. Für die Amplifikation wurde die TaG/-DNA-Polymerase, wenn nicht anders angegeben, von Gibco BRL verwendet. Das δ'-Ende der cDNA wurde mit dem T3-Primer (20 mer) von Stratagene und dem spezifischen RückprimerThe following program was used for the amplification: δ min at 96 ° C, followed by 30 cycles of 20 s at 96 ° C, 1 min at 40 ° C (binding temperature, T m ) and 2 min at 72 ° C, 1 cycle of 10 min at 72 ° C. Unless otherwise stated, Gibco BRL used the TaG / DNA polymerase for the amplification. The δ 'end of the cDNA was treated with the Stratagene T3 primer (20 mer) and the specific back primer
BN3 (δ'-TTATGCGTCCATTTCCACCA-3') wie beschrieben mittels PCR amplifiziert, nur daß die Tm δδ °C betrug.BN3 (δ'-TTATGCGTCCATTTCCACCA-3 ') amplified by PCR as described, except that the Tm was δδ ° C.
Um das 3'-Ende der DNA zu amplifizieren, wurde cDNA aus mRNA reifender Embryonen von ß. napus cv. Drakkar eingesetzt. Dazu wurde mRNA mit Hilfe von oligo(dT) Dynabeads nach Gebrauchsanweisung der Fa. Dynal GmbH (Hamburg) aus reifenden Embryonen von ß. napus cv. Drakkar isoliert. Diese mRNA wurde mittels der Reversen Transkriptase Reaktion zur Einzelstrang cDNA Synthese mit dem SuperScript Preamplification System (Gibco BRL) und einem synthetischen oligo(dT)-PrimerIn order to amplify the 3 'end of the DNA, cDNA was made from mRNA maturing embryos of ß. napus cv. Drakkar used. For this purpose, mRNA was extracted from ß maturing embryos using oligo (dT) Dynabeads according to the instructions for use from Dynal GmbH (Hamburg). napus cv. Drakkar isolated. This mRNA was converted into a single-strand cDNA synthesis using the reverse transcriptase reaction using the SuperScript preamplification system (Gibco BRL) and a synthetic oligo (dT) primer
(δ'-GA TCTAGA CTCGAG GTCGAC T14-3'), der die drei Restriktionsschnittstellen für Xbal, Xhol und Sall trägt (unterstrichen), eingesetzt. Die synthetisierte cDNA wurde über SizeSep 400 Säulen der Fa. Pharmacia nach deren Anweisung gereinigt. Anschließend wurde das 3'-Ende der DNA mit dem spezifischen Forwärtsprimer(δ'-GA TCTAGA CTCGAG GTCGAC T 14 -3 '), which carries the three restriction sites for Xbal, Xhol and Sall (underlined). The synthesized cDNA was purified on SizeSep 400 columns from Pharmacia according to their instructions. Then the 3 'end of the DNA was with the specific forward primer
BN4 (δ'-TTCTTTGGCGGGTTGCAGTT-3') und einem synthetischen oligo(dT)-PrimerBN4 (δ'-TTCTTTGGCGGGTTGCAGTT-3 ') and a synthetic oligo (dT) primer
(5'-GA TCTAGA CTCGAG GTCGAC T4-3') mittels der o.g. PCR-Bedingungen bei Tm 54 °C amplifiziert. Die Klonierung und Sequenzierung der doppelsträngigen cDNA-Fragmente aus den verschiedenen PCR-Amplifikationen (δ71 bp, δ'- und 3'-Ende) erfolgte wie beschrieben (P. Sperling et al. (1996), s.o.): Die DNA-Fragmente wurden mit dem SureClone Ligation Kit (Pharmacia, Freiburg) in den Plasmidvektor pUC1δ/Smal legiert, in E. coli XLIblue (Stratagene) transformiert und mit dem ABI PRISM Dye Primer Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Weiterstadt) beidsträngig sequenziert. Die, aus den sich überlappenden Teilsequenzen, abgeleitete Länge des vollständige Klons beträgt 1δ94 bp (Abb. 1), der für ein offenes Leseraster von 449 Aminosäuren codiert (Abb.2). Spezifische Primer(5'-GA TCTAGA CTCGAG GTCGAC T 4 -3 ') amplified using the above-mentioned PCR conditions at Tm 54 ° C. The cloning and sequencing of the double-stranded cDNA fragments from the different PCR amplifications (δ71 bp, δ 'and 3' end) was carried out as described (P. Sperling et al. (1996), see above): The DNA fragments were alloyed with the SureClone Ligation Kit (Pharmacia, Freiburg) into the plasmid vector pUC1δ / Smal, transformed into E. coli XLIblue (Stratagene) and sequenced on both strands with the ABI PRISM Dye Primer Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Weiterstadt). The length of the complete clone derived from the overlapping partial sequences is 1δ94 bp (FIG. 1), which codes for an open reading frame of 449 amino acids (FIG. 2). Specific primers
BNδ (δ'-AACCATCTCTGTTTCAAC-3*) und BN6 (δ'-CAA GTGATGATGAGTTAC-3'),BNδ (δ'-AACCATCTCTGTTTCAAC-3 * ) and BN6 (δ'-CAA GTGATGATGAGTTAC-3 '),
die von den δ'- und 3'-untranslatierten Regionen abgeleitet wurden, wurden in einer weiteren PCR (Tm δδ °C) mit cDNA aus ß. napus cv. Drakkar eingesetzt. Diese Reaktion wurde mit der P u-DNA-Polymerase (Stratagene) durchgeführt. Ein vollständiger Klon von 1δ02 bp (PCR-Klon 1) wurde isoliert, mit dem SureClone Ligation Kit (Pharmacia) in pUC1δ/Smal legiert und in in E. coli XLIblue (Stratagene) transformiert. Der Klon wurde beidsträngig mit dem ABI PRISM Dye Terminator Kit (Perkin-Elmer) sequenziert und stimmt mit der Nukleotidsequenz in Fig. 1 und und der Aminosäuresequenz in Fig. 2 überein.which were derived from the δ'- and 3'-untranslated regions were analyzed in a further PCR (T m δδ ° C) with cDNA from ß. napus cv. Drakkar used. This reaction was carried out with the P u-DNA polymerase (Stratagene). A complete clone of 1δ02 bp (PCR clone 1) was isolated, alloyed with the SureClone Ligation Kit (Pharmacia) in pUC1δ / Smal and transformed into E. coli XLIblue (Stratagene). The clone was sequenced with the ABI PRISM Dye Terminator Kit (Perkin-Elmer) and matches the nucleotide sequence in FIG. 1 and the amino acid sequence in FIG. 2.
Für die spätere Expression in Hefe wurde ein vollständiger Klon (1347 bp), der die kodierende Sequenz beinhaltete, mittels PCR mit den abgeleiteten PrimernFor later expression in yeast, a complete clone (1347 bp), which contained the coding sequence, was PCR-derived with the derived primers
BN7, vorwärts δ'-CCGGTACCATGTCGGAGCAGACAAAG-3' und BN8, revers δ'-CCGAATTC CTAGCCATGAGTATTCAGA-3'BN7, forward δ'-CCGGTACCATGTCGGAGCAGACAAAG-3 'and BN8, reverse δ'-CCGAATTC CTAGCCATGAGTATTCAGA-3'
bei Tm δ6 °C amplifiziert. Start- und Stopcodon sind fett gedruckt und die angefügten Restriktionsschnittstellen Kpnl und EcoRI sind unterstrichen. Ein vollständiger Klon von 1363 bp (PCR-Klon 2) wurde isoliert und mit Hilfe des pGEM-T Vektor Systems von Promega in E coli XLIblue kloniert. Zur Überprüfung wurde dieser Klon mit dem ABI PRISM Dye Primer Kit (Perkin-Elmer) ansequenziert.amplified at T m δ6 ° C. The start and stop codons are printed in bold and the restriction interfaces Kpnl and EcoRI are underlined. A complete clone of 1363 bp (PCR clone 2) was isolated and using the pGEM-T vector system cloned by Promega in E coli XLIblue. To check this clone was sequenced with the ABI PRISM Dye Primer Kit (Perkin-Elmer).
Beispiel 2: Isolierung und Klonierung von s/dl aus A. thaliana Um das s/c/1 Gen aus Arabidopsis thaliana zu isolieren, wurde eine TBLASTN-Suche (S. F. Altschul et al., „Basic local alignment search tool", J. Mol. Biol. 215: 403-410 (1990)) in Datenbanken mit der abgeleiteten Proteinsequenz aus ß. napus (Fig. 2) durchgeführt. Teile der Proteinsequenz aus ß. napus wiesen eine signifikante Ähnlichkeit zu folgenden EST-Klonen aus A. thaliana auf, deren EMBL Accession- Nummern lauten: T42569 (27-93), N37δδ8 (33-196), F13726 (113-201), T42306 (366- 396), F13717 (421-449). Die Zahlen in Klammern beziehen sich auf die Aminosäurepositionen der Rapssequenz (Fig. 2), die von diesen EST-Klonen abgedeckt werden.Example 2: Isolation and cloning of s / dl from A. thaliana In order to isolate the s / c / 1 gene from Arabidopsis thaliana, a TBLASTN search (SF Altschul et al., "Basic local alignment search tool", J. Mol. Biol. 215: 403-410 (1990)) in databases with the derived protein sequence from ß.napus (Fig. 2.) Parts of the protein sequence from ß.napus showed a significant similarity to the following EST clones from A. thaliana whose EMBL accession numbers are: T42569 (27-93), N37δδ8 (33-196), F13726 (113-201), T42306 (366-396), F13717 (421-449). The numbers in brackets refer to to the amino acid positions of the rapeseed sequence (Fig. 2) covered by these EST clones.
Spezifische Oligonucleotidprimer wurden von den Nukleotidsequenzen der EST- KloneSpecific oligonucleotide primers were derived from the nucleotide sequences of the EST clones
T42569: (AT1 , vorwärts) δ'-GCGATTCAAGGCAAGGTCTAC-S' und F13717: (AT2, revers) δ'-TTAGCCATGAGTATTCAAAGC-3* T42569: (AT1, forward) δ'-GCGATTCAAGGCAAGGTCTAC-S 'and F13717: (AT2, reverse) δ'-TTAGCCATGAGTATTCAAAGC-3 *
abgeleitet, wobei das Stopcodon Fett gedruckt ist. Diese Primer wurden für die PCR- Amplifikation (2 min bei 9δ °C, 30 Zyklen mit 20 s bei 9δ °C, 30 s bei Tm δ9 °C, 1 min bei 72 °C, 1 Zyklus 10 min bei 72 °C) eines 1272 bp DNA-Fragmentes aus einer lambda-ZAP cDNA-Bank aus A. thaliana eingesetzt. Diese cDNA-Bank wurde von dem Genetic Stock Center des Max-Planck Institutes in Köln bezogen, die hauptsächlich aus grünen Pflanzenteilen (Blätter, einige Blüten, wenig Wurzeln) isoliert worden war. Das δ'- bzw. 3'-Ende wurde mittels o.g. PCR (Tm 60 °C) mit der Primer-Kombination T3-Primer (Stratagene) und AT2 bzw. T7-Primer und AT1 amplifiziert. Das 1272 bp DNA-Fragment (PCR-Klon 3) wurde in pUC 19/Smal und die 5'- und 3'- DNA-Fragmente wurden mit dem pGEM-T Vector System (Promega) in E. coli XLIblue (MRF\ Stratagene) kloniert. Die Sequenzierung erfolgte mit dem dem ABI PRISM Dye Primer Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Weiterstadt). Aus diesen drei überlappenden Teilsequenzen konnte eine vollständige Sequenz von 167δ bp (Abb. 3) abgeleitet werden, die für ein offenes Leseraster von 449 Aminosäuren kodiert (Abb. 4). Ein vollständiger Klon, der die kodierende Sequenz beinhaltete, wurde mittels PCR mit den abgeleiteten Primernderived, with the stop codon printed in bold. These primers were used for the PCR amplification (2 min at 9δ ° C, 30 cycles with 20 s at 9δ ° C, 30 s at T m δ9 ° C, 1 min at 72 ° C, 1 cycle 10 min at 72 ° C ) a 1272 bp DNA fragment from a lambda-ZAP cDNA library from A. thaliana. This cDNA bank was obtained from the Genetic Stock Center of the Max Planck Institute in Cologne, which was mainly isolated from green parts of the plant (leaves, some flowers, few roots). The δ 'or 3' end was amplified by means of the above-mentioned PCR (T m 60 ° C.) with the primer combination T3 primer (Stratagene) and AT2 or T7 primer and AT1. The 1272 bp DNA fragment (PCR clone 3) was converted into pUC 19 / Smal and the 5 'and 3' DNA fragments were analyzed with the pGEM-T Vector System (Promega) in E. coli XLIblue (MRF \ Stratagene ) cloned. The sequencing was carried out using the ABI PRISM Dye Primer Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Weiterstadt). From these three overlapping partial sequences a complete sequence of 167δ bp (Fig. 3) could be derived, which for an open reading frame of 449 amino acids coded (Fig. 4). A complete clone, which contained the coding sequence, was PCR-derived with the derived primers
AT3, vorwärts: δ'-CCGGTACCATGGCGGAAGAGACGGAG-3' und AT4, revers: δ'-CCGAATTC TTAGCCATGAGTATTCAAAGC-3'AT3, forward: δ'-CCGGTACCATGGCGGAAGAGACGGAG-3 'and AT4, reverse: δ'-CCGAATTC TTAGCCATGAGTATTCAAAGC-3'
bei Tm 66 °C amplifiziert. Start- und Stopcodon sind fett gedruckt und die angefügten Restriktionsschnittstellen Kpnl und EcoRI für die spätere Klonierung in einen Hefe- Expressionsvektor sind unterstrichen. Ein vollständiger Klon von 1363 bp (PCR- Klon 4) wurde isoliert, mit dem pGEM-T Vektor von Promega kloniert und in E. coli XLIblue transformiert. Dieser Klon wurde mit dem ABI PRISM Dye Terminator Kit (Perkin-Elmer) beidsträngig sequenziert und stimmt mit der Nukleotidsequenz in Fig. 3 und und der Aminosäuresequenz in Fig. 4 überein.amplified at T m 66 ° C. The start and stop codons are printed in bold and the restriction sites Kpnl and EcoRI added for later cloning into a yeast expression vector are underlined. A complete clone of 1363 bp (PCR clone 4) was isolated, cloned with the pGEM-T vector from Promega and transformed into E. coli XLIblue. This clone was sequenced on both strands with the ABI PRISM Dye Terminator Kit (Perkin-Elmer) and corresponds to the nucleotide sequence in FIG. 3 and the amino acid sequence in FIG. 4.
Die s/c/1-Nukleotidsequenzen aus ß. napus und A. thaliana weisen beide ein offenes Leseraster gleicher Länge auf, das am N-Terminus 9 Aminosäuren kürzer ist als das entsprechende Protein aus der Sonnenblume (P. Sperling et al. (199δ), s.o.). Die zwei abgeleiteten Polypeptide von ca. 61-62 kD weisen untereinander 76 % identische Aminosäuren auf und 6δ % bzw. 64 % zu der Sonnenblumensequenz. Die höchste Ähnlichkeit der s/c 1 -Proteine besteht zu der delta-6 Glycerolipid- Desaturase aus Borretsch (O. Sayanova et al. (1997), s. o.), dessen Proteinsequenz um eine Aminosäure kürzer ist, wobei 60 % bzw. 66 % der Aminosäuren identisch sind (Fig. δ).The s / c / 1 nucleotide sequences from β. napus and A. thaliana both have an open reading frame of the same length, which is 9 amino acids shorter at the N-terminus than the corresponding protein from the sunflower (P. Sperling et al. (199δ), see above). The two derived polypeptides of approx. 61-62 kD have 76% identical amino acids to each other and 6δ% and 64% to the sunflower sequence. The greatest similarity between the s / c 1 proteins and the delta-6 glycerolipid desaturase from Borage (O. Sayanova et al. (1997), see above), whose protein sequence is one amino acid shorter, 60% and 66% respectively the amino acids are identical (Fig. δ).
Beispiel 3: Klonierung und Expression von s/c/1 in Saccharomyces cerevisiae: Die Klonierung und Expression von s/c 1 erfolgte in Anlehnung an die erfolgreiche Expressionmethode des fac/2-Gens aus A. thaliana in Hefe (S. Kajiwara et al., „Polyunsaturated fatty Acid Biosynthesis in Saccaromyces cerecisiae: Expression of Ethanol Tolerance and the FAD2 Gene from Arabidopsis thaliana", Appl. Environ. Microbiol. 62: 4309-4313 (1996)). Die amplifizierte s/c/1 DNA aus ß. napus und A. thaliana (PCR-Klone 2 und 4), die in die multiple Klonierungsstelle des Vektors pGEM-T Vektors (Promega) kloniert worden war (s.o.), wurde mit den Restriktionsendonukleasen Kpnl und EcoRI geschnitten. Die 1 ,4 Kb Kpnl/EcoRI- Fragmente wurden in die Kpnl/EcoRI- Stelle des gezippten Hefe-E. coli shuttle- Expressionsvektors pYES2 legiert (Invitrogen Co.). Die daraus, resultierenden neuen Plasmide, pYES2Bn und pYES2At, sind in Abb. 6 und Abb. 7 dargestellt und wurden in E. coli TOP10F' (Invitrogen Co.) transformiert.Example 3: Cloning and expression of s / c / 1 in Saccharomyces cerevisiae: The cloning and expression of s / c 1 was based on the successful expression method of the fac / 2 gene from A. thaliana in yeast (S. Kajiwara et al ., "Polyunsaturated fatty acid biosynthesis in Saccaromyces cerecisiae: Expression of Ethanol Tolerance and the FAD2 Gene from Arabidopsis thaliana", Appl. Environ. Microbiol. 62: 4309-4313 (1996)). The amplified s / c / 1 DNA from ß napus and A. thaliana (PCR clones 2 and 4), which had been cloned into the multiple cloning site of the vector pGEM-T vector (Promega) (see above), were cut with the restriction endonucleases Kpnl and EcoRI Kpnl / EcoRI- Fragments were inserted into the Kpnl / EcoRI site of the zipped yeast E. coli shuttle expression vector pYES2 alloyed (Invitrogen Co.). The resulting new plasmids, pYES2Bn and pYES2At, are shown in Fig. 6 and Fig. 7 and were transformed into E. coli TOP10F '(Invitrogen Co.).
Die DNA-Maxipräparation wurde mit dem Plasmid Maxi Kit (Qiagen) durchgeführt. Die isolierten Plasmide pYES2Bn und pYES2At wurden zur Kontrolle nochmals mit dem ABI PRISM Dye Primer Ready Reaction Kit (Perkin-Elmer) ansequenziert und dann in S. cerevisiae INVSd (Invitrogen Co.) mit der Polyethylenglycol-Methode (M. von Pein, Dissertation, Heinrich Heine-Universität Düsseldorf (1992)) transformiert.The DNA maxi preparation was carried out with the plasmid Maxi Kit (Qiagen). The isolated plasmids pYES2Bn and pYES2At were checked again with the ABI PRISM Dye Primer Ready Reaction Kit (Perkin-Elmer) and then in S. cerevisiae INVSd (Invitrogen Co.) with the polyethylene glycol method (M. von Pein, dissertation, Heinrich Heine University Düsseldorf (1992)) transformed.
Die Selektion erfolgte auf Agarplatten aus komlettem Minimal-Dropout-Uracil (CM)- Medium mit 2% Glucose (F. M. Asubel et al., „Current Protocols in Molecular Biology", John Wiley & Sons, New York 1996). Die Überprüfung der transgenen Hefekolonien erfolgte mittels einer Minipräparation von Hefeplasmid-DNA (Asubel et al. (1996), s.o.) deren Retransformation in E. coli TOP10F', anschließender Minipräparation und Restriktionsanalyse der E.co//'-Plasmid-DNA mit Kpnl/EcoRI. Für den analytischen Vergleich der Transformanten mit dem Hefe-Wildtyp wurde auch der ungeschnittene pYES2-Vektor in INVSd (Kontrolle) transformiert.The selection was carried out on agar plates from complete minimal dropout uracil (CM) medium with 2% glucose (FM Asubel et al., "Current Protocols in Molecular Biology", John Wiley & Sons, New York 1996). The review of the transgenic Yeast colonies were carried out by means of a mini preparation of yeast plasmid DNA (Asubel et al. (1996), see above) whose retransformation in E. coli TOP10F ', subsequent mini preparation and restriction analysis of the E.co// ' plasmid DNA with Kpnl / EcoRI the analytical comparison of the transformants with the wild-type yeast also transformed the uncut pYES2 vector into INVSd (control).
Die Vorkultur erfolgte durch Animpfen von 2-δ ml CM- 2 % Raffinose-Medium mit einer transgenen Hefekolonie und anschließender Inkubation für 2 d bei 30 °C im Roller bis zu einer optischen Dichte bei 600 nm (ODβoo) von 4-δ. Für die Hauptkultur wurde CM- 2 % Raffinose-Medium mit einem Aliquot der Vorkultur (600 fache Verdünnung) ad OD60o 0,01-0,02 angeimpft und 24 h bei 30 °C, 2δ0 rpm im Schüttler inkubiert. Die Induktion der Testkulturen erfolgte in der logarithmischen Wachstumsphase (OD6oo 0,1-0,6) durch Zugabe von Galaktose ad 1 ,8 % . Die Ernte der induzierten Zellen erfolgte nach weiteren 24 h aeroben Wachstum bei 30 °C bei OD60o 4-δ.The preculture was carried out by inoculating 2-δ ml of CM- 2% raffinose medium with a transgenic yeast colony and then incubating for 2 d at 30 ° C. in a roller up to an optical density at 600 nm (ODβoo) of 4-δ. For the main culture, CM-2% raffinose medium was inoculated with an aliquot of the preculture (600-fold dilution) to OD 60 or 0.01-0.02 and incubated in the shaker at 30 ° C., 2δ0 rpm for 24 h. The test cultures were induced in the logarithmic growth phase (OD 6 oo 0.1-0.6) by adding galactose ad 1.8%. The induced cells were harvested after a further 24 h of aerobic growth at 30 ° C. at OD 60 o 4-δ.
Beispiel 4: Analyse der langkettigen Basen aus den Sphingolipiden der Hefetransformanten Die induzierten Hefezellen wurden durch 10 min Zentrifugation bei 2000 g geerntet, zweimal mit Aqua dest. gewaschen, 20 min in Aqua dest. abgekocht, und nach dem Abkühlen auf Eis erneut sedimentiert.Example 4: Analysis of the long-chain bases from the sphingolipids of the yeast transformants The induced yeast cells were harvested by centrifugation at 2000 g for 10 min, twice with distilled water. washed, 20 min in distilled water boiled, and sedimented again after cooling on ice.
Da S. cerevisiae hauptsächlich nur die schwer extrahierbaren Sphingophosphoglycolipide enthält, wurden die langkettigen Basen (LCB) durch starke alkalische Hydrolyse (24 h bei 110 °C) ganzer Zellen (350 mg Frischgewicht) in 10% Ba(OH)2/Dioxan (1 :1 , v/v) freigesetzt (W. R. Morrison et al., „Polar lipids in bovine milk II. Long-chain Bases, normal and 2-hydroxy fatty acids, and isomeric eis and trans monoenoic fatty acids in the sphingolipids", Biochim. Biophys. Acta 202: 460-467 (1970)). Die LCB wurden aus dem Hydrolysat ad CHCI3/Dioxan/H20 (6:1 :5) extrahiert, die CHC -Phase abdestilliert. Die freien LCB des Hydrolysats wurden direkt in ihre Dinitrophenyl-Derivate überführt (K.-A. Karisson, „On the occurrence of sphingolipid long-chain bases", Chem. Phys. Lipids 5: 6-43 (1970)). Die Dinitrophenyl-LCB wurden mit CHCI3/Methanol/H20 (δ:4:3) extrahiert, dünnschichtchromatographisch in CHCI3/Methanol (90:10) gereinigt (K.-A. Karisson (1970), s.o.) und mit Methanol aus dem Kieselgel extrahiert.Since S. cerevisiae mainly contains only the hard-to-extract sphingophosphoglycolipids, the long-chain bases (LCB) were obtained by strong alkaline hydrolysis (24 h at 110 ° C) of whole cells (350 mg fresh weight) in 10% Ba (OH) 2 / dioxane (1 : 1, v / v) released (WR Morrison et al., "Polar lipids in bovine milk II. Long-chain bases, normal and 2-hydroxy fatty acids, and isomeric eis and trans monoenoic fatty acids in the sphingolipids", Biochim Biophys Acta 202: 460-467 (1970)) The LCB were extracted from the hydrolyzate ad CHCI 3 / dioxane / H 2 0 (6: 1: 5), the CHC phase was distilled off, and the free LCB of the hydrolyzate were removed converted directly into their dinitrophenyl derivatives (K.-A. Karisson, "On the occurrence of sphingolipid long-chain bases", Chem. Phys. Lipids 5: 6-43 (1970)). The dinitrophenyl LCBs were extracted with CHCI 3 / methanol / H 2 0 (δ: 4: 3), purified by thin layer chromatography in CHCI 3 / methanol (90:10) (K.-A. Karisson (1970), see above) and with Methanol extracted from the silica gel.
Für die Analyse der Dinitrophenyl-LCB wurde eine Reverse Phase-High Performance Liquid Chromatography (RP-HPLC)-Methode entwickelt. Die Trennung der verschiedenen Spezies erfolgte mit einer ODS Hypersil® RP1δ-Säule (5 μm, 26 x 4,6 cm) von der Fa. Bischoff. Die Elution erfolgte mit einem linearen Gradienten bei einer Flußrate von 1 ml/min: Von 80 % Methanol/Acetonitrile/2-Propanol (10:3:1 , v/v/v) und 20 % Aqua dest. auf 0 % Aqua dest. in 40 min. Die Elution der Dinitrophenyl-Derivate wurde bei 360 nm massenproportional detektiert (Fig. 8). Die Referenz-LCB wurden von der Fa. Sigma bezogen (Fig. δ A). Die HPLC-Analyse zeigte, daß transgene Hefezellen, die das Plasmid pYES2At bzw. pYES2Bn enthalten, mindestens zwei neuartige LCB produzieren (Abb. δ C, D), die in Wildtyp- und mit pYES2 transformierten Hefen (Fig. δ B) nicht enthalten sind. Kalkuliert aus den HPLC-Daten, betrug das Verhältnis der neuartigen eis- und trans- Phytosphingenine (t1δ:1) bei transgenen Hefen mit pYES2Bn 1 :6,7 und mit pYES2At 1 :3. Die Stereoisomere delta-δ und delta-9 wurden durch die HPLC nicht getrennt.A reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the analysis of dinitrophenyl LCB. The different species were separated using an ODS Hypersil ® RP1δ column (5 μm, 26 x 4.6 cm) from Bischoff. Elution was carried out using a linear gradient at a flow rate of 1 ml / min: from 80% methanol / acetonitrile / 2-propanol (10: 3: 1, v / v / v) and 20% distilled water. to 0% aqua dest. in 40 min. The elution of the dinitrophenyl derivatives was detected at 360 nm in proportion to the mass (FIG. 8). The reference LCB were obtained from Sigma (FIG. Δ A). The HPLC analysis showed that transgenic yeast cells, which contain the plasmid pYES2At or pYES2Bn, produce at least two novel LCB (Fig. Δ C, D) which do not contain in wild-type and pYES2-transformed yeast (Fig. Δ B) are. Calculated from the HPLC data, the ratio of the novel eis and trans-phytosphingenins (t1δ: 1) was 1: 6.7 for transgenic yeasts with pYES2Bn and 1: 3 with pYES2At. The stereoisomers delta-δ and delta-9 were not separated by HPLC.
Beispiel δ: Analyse der neuartigen langkettigen Sphingobasen mittels NMR und MS Isolierung und Derivatisierung der Phytosphingenine: Für eine chemische Strukturanalyse wurden die LCB aus transgenen Hefezellen (δ,7 g Frischgewicht) mittels alkalischer Hydrolyse isoliert (siehe Beispiel 4.). Die Fraktion der freien C1δ- Trihydroxybasen (Phytosphinganin und Phytosphingenin, Rf 0,34) wurde über Dünnschichtchromatographie in CHCI3/Methanol/NH4 (40:40:1) von den restlichen Basen des Hydrolysats abgetrennt (M. Ohnishi et al., Biochim. Biophys. Acta 752: 416-422 (1933)), mit CHCI3/Methanol/1 N KOH (2:1 :0,75) extrahiert und mit Essigsäureanhydrid, 4-(Dimethylamino)-pyridin in Pyridin per-O-acetyliert (C. M. Gupta et al., „Glycerophospholipid synthesis: improved general method and new analogs containing photoactivable groups", Proc. natl. Acad. Sei. USA 74: 4315-4319 (1977)). Die per-O-acetylierten C13-Trihydroxybasen wurden in n-Hexan gegen Wasser (1:1) extrahiert und in 100% Diethylether dünnschichtchromatographisch gereinigt. Die Detektion erfolgte mit 0,2 % methanolischer δ-Anilinonaphthalin-1- sulfonsäure unter UV-Licht und die Extraktion erfolgte mit n-Hexan. Die Auftrennung der per-O-acetylierten Basenfraktion (0,73 mg) in Phytosphinganin (125 μg t1δ:0, Rf 0,46), in trans- (300 μg t18:1l, Rf 0,44) und in c/s-Phytosphingenin (100 μg t1δ:1c, Rf 0,44) erfolgte dünnschichtchromatographisch über 10 % ige Silbernitrat- Kieselgelplatten (O. Renkonen et al., „Structure of plasma sphingadienine", J. Lipid Res. 10: 6δ7-693 (1969)) in CHCI3/Methanol (95:5) bei 4 °C. Die Detektion der Banden erfolgte mit 0,2 % methanolischem Dichlorofluorescein unter UV-Licht und die Extraktion erfolgte mit n-Hexan.Example δ: Analysis of the novel long-chain sphingobases using NMR and MS Isolation and derivatization of the phytosphine genes: For a chemical structure analysis, the LCB were isolated from transgenic yeast cells (δ, 7 g fresh weight) by means of alkaline hydrolysis (see Example 4). The fraction of the free C1δ trihydroxy bases (phytosphinganin and phytosphingenin, R f 0.34) was separated from the remaining bases of the hydrolyzate by thin layer chromatography in CHCI 3 / methanol / NH 4 (40: 40: 1) (M. Ohnishi et al. , Biochim. Biophys. Acta 752: 416-422 (1933)), extracted with CHCI 3 / methanol / 1N KOH (2: 1: 0.75) and extracted with acetic anhydride, 4- (dimethylamino) pyridine in pyridine. O-acetylated (CM Gupta et al., "Glycerophospholipid synthesis: improved general method and new analogs containing photoactivable groups", Proc. Natl. Acad. Sci. USA 74: 4315-4319 (1977)). The per-O-acetylated C13-trihydroxy bases were extracted in n-hexane against water (1: 1) and purified by thin layer chromatography in 100% diethyl ether, detection with 0.2% methanolic δ-anilinonaphthalene-1-sulfonic acid under UV light and extraction with n -Hexane: The separation of the per-O-acetylated base fraction (0.73 mg) into phytosphinganine (125 μg t1δ: 0, R f 0 , 46), in trans- (300 μg t18: 1 l , R f 0.44) and in c / s-phytosphingenin (100 μg t1δ: 1 c , R f 0.44), thin-layer chromatography was carried out using 10% silver nitrate Silica gel plates (O. Renkonen et al., "Structure of plasma sphingadienine", J. Lipid Res. 10: 6δ7-693 (1969)) in CHCI 3 / methanol (95: 5) at 4 ° C. The bands were detected at 0.2 % methanolic dichlorofluorescein under UV light and the extraction was carried out with n-hexane.
Λ//W/?-SpeWros/ op/'e:1H-NMR-Spektren wurden mit einem 600 MHz Bruker Avance DRX 600 Spektrometer, ausgerüstet mit einem Mikroprobenkopf (PH TXI 600SB), mit Kapillarröhrchen von 2,5 mm O.D. (Wilmad, Buena, NJ, USA) gemessen. Die per-O-acetylierten Proben (60 - 300 μg) wurden in 100 μl CDCI3 (Cambridge Isotope Lab., MA., USA) gelöst und ihre Spektren bei 300 K mit TMS als internem Standard (5H= 0,000 ppm) aufgenommen. Ein- und zweidimensionale homonucleare 1H, 1H COSY-Experimente wurden mit der Standard-Bruker-Software (XWINNNMR, Version 1.3) dargestellt. GC-MS-Analyse: Die gaschromatographischeΛ // W /? - SpeWros / op / ' e: 1 H-NMR spectra were recorded with a 600 MHz Bruker Avance DRX 600 spectrometer, equipped with a micro probe head (PH TXI 600SB), with capillary tubes of 2.5 mm OD ( Wilmad, Buena, NJ, USA). The per-O-acetylated samples (60-300 μg) were dissolved in 100 μl CDCI 3 (Cambridge Isotope Lab., MA., USA) and their spectra recorded at 300 K with TMS as internal standard (5H = 0.000 ppm). One- and two-dimensional homonuclear 1 H, 1 H COZY experiments were shown with the standard Bruker software (XWINNNMR, version 1.3). GC-MS analysis: The gas chromatographic
Massenspektroskopie (GC-MS) wurde mit einem Hewlett-Packard Spektrometer Modell 5989 mit einer HP-5 Kapillarsäule (30 m x 0,2δ mm) durchgeführt. Die folgenden Temperaturgradienten wurden für die Analyse der verschiedenen Derivate benutzt: Per-O-acetylierte Phytosphingenine: 3 min bei 230 °C, Gradient von δ °C/min ad 330 °C und mittelkettige Fettsäuremethylester: 3 min bei 100 °C, Gradient von 10 °C/min ad 330 °C. GC-MS-Analyse wurde im Cl- (mit Ammoniak) und El- Mode (70 eV) durchgeführt.Mass spectroscopy (GC-MS) was carried out with a Hewlett-Packard model 5989 spectrometer with an HP-5 capillary column (30 m x 0.2δ mm). The following temperature gradients were used for the analysis of the various derivatives: Per-O-acetylated phytosphingenins: 3 min at 230 ° C, gradient from δ ° C / min to 330 ° C and medium-chain fatty acid methyl ester: 3 min at 100 ° C, gradient from 10 ° C / min to 330 ° C. GC-MS analysis was carried out in Cl (with ammonia) and El mode (70 eV).
Derivatisierung der Phytosphingenine für GC-MSDerivatization of phytosphine genes for GC-MS
A) Bleitetraacetat-Oxidation: Ein Aliquot der unfraktionierten, peracetylierten C18- Trihydroxybasen (0,36 mg) wurden mit Natriummethylat desacyiiert und anschließend mit Pb(OAc)4 in Chloroform oxidiert. Die resultierenden Aldehyde wurden in Chloroform extrahiert, zur Trockne eingedampft und mit LiAIH in Ether zu den entsprechenden Alkoholen reduziert. 1/10 der Alkohole wurde mit BSTFA (Sigma) in ihre Trimethylsilyl-Derivate überführt und direkt mittels GC-MS analysiert. Die restlichen Alkohole (9/10) wurden mit Nikotinsäurechlorid in Pyridin zu Nikotinaten umgesetzt, in n-Hexan gegen Wasser extrahiert und mittels GC-MS analysiert.A) Lead tetraacetate oxidation: An aliquot of the unfractionated, peracetylated C18-trihydroxy bases (0.36 mg) were desacyated with sodium methylate and then oxidized with Pb (OAc) 4 in chloroform. The resulting aldehydes were extracted into chloroform, evaporated to dryness and reduced to the corresponding alcohols with LiAIH in ether. 1/10 of the alcohols were converted into their trimethylsilyl derivatives with BSTFA (Sigma) and analyzed directly by GC-MS. The remaining alcohols (9/10) were converted to nicotinates with nicotinic acid chloride in pyridine, extracted into water in n-hexane and analyzed by GC-MS.
B) Kaliumpermanganat-Oxidation: Ein Aliquot der peracetylierten C1δ- Trihydroxybasen wurde unter alkalischen Bedingungen mit KMn04 in Methanol/Wasser (2:1) oxidiert. Nach dem Ansäuern wurden die resultierenden Fettsäuren extrahiert und mit etherischem Diazomethan in ihre Methyl-Ester überführt und mittels GC-MS analysiert.B) Potassium permanganate oxidation: An aliquot of the peracetylated C1δ-trihydroxy bases was oxidized under alkaline conditions with KMn0 4 in methanol / water (2: 1). After acidification, the resulting fatty acids were extracted and converted into their methyl esters with ethereal diazomethane and analyzed by GC-MS.
Die Fraktion der per-O-acetylierten C1δ-Trihydroxybasen aus den mit pYES2At transformierten Hefen wurde mittels GC-MS analysiert, wobei drei distinkte Peaks erhalten wurden. Ein Peak, der bei 15,72 min eluierte, wurde als 2-N-acetamido- 1 ,3,4-tri-O-acetyl-octadecan (Phytosphinganin, t1δ:0) identifiziert. Die zusätzlichen beiden Peaks eluierten bei 15,30 und 15,46 min wurden als als 2-N-acetamido-1 ,3,4- tri-O-acetyl-octadecen (m/z"144, 423[M-60]+, 433[M]+ ) (Phytosphingenin, t1δ:1) identifziert. Das t1δ:0 und die beiden t1δ:1 -Isomere lagen im Verhältnis 3:2:1 vor. Die, nach Bleitetraacetat-Oxidation erhaltenen, zwei Nikotinat-Derivate von t1δ:1 führten bei der GC-MS-Analyse zu zwei Peaks (15, δO und 15,9δ min) mit dem erwarteten, molekularen Masseion (M= 331). Basierend auf das beobachtete Fragmentierungsmuster der Nikotinate, konnte die Position der Doppelbindung nur annäherungsweise im ersten Peak zwischen C6 und C7 (Penta-Δ6-decen, m/z = 137, 151 , 165, 173, 192, 206, 21 δ, 232) und im zweiten Peak zwischen C7 und Cδ (Penta-Δ5-decen, m/z = 137, 151 , 165, 17δ, 192, 204, 21 δ, 232) lokalisiert werden.The fraction of the per-O-acetylated C1δ-trihydroxy bases from the yeast transformed with pYES2At was analyzed by GC-MS, whereby three distinct peaks were obtained. A peak eluting at 15.72 min was identified as 2-N-acetamido-1, 3,4-tri-O-acetyl-octadecane (phytosphinganine, t1δ: 0). The additional two peaks eluted at 15.30 and 15.46 min were considered as 2-N-acetamido-1, 3,4-tri-O-acetyl-octadecene (m / z " 144, 423 [M-60] + , 433 [M] + ) (phytosphingenin, t1δ: 1). The t1δ: 0 and the two t1δ: 1 isomers were in a ratio of 3: 2: 1. The two nicotinate derivatives obtained after lead tetraacetate oxidation from t1δ: 1 resulted in two peaks (15, δO and 15.9δ min) with the expected molecular mass ion (M = 331) in the GC-MS analysis. Based on the observed fragmentation pattern of the nicotinates, the position of the double bond could only be approximated in the first peak between C6 and C7 (penta-Δ6-decene, m / z = 137, 151, 165, 173, 192, 206, 21 δ, 232) and located in the second peak between C7 and Cδ (penta-Δ5-decene, m / z = 137, 151, 165, 17δ, 192, 204, 21 δ, 232).
Für eine eindeutige Lokalisation der Doppelbindung wurde die Fraktion der C13- Trihydroxybasen mit Kaliumpermanganat oxidiert und in ihre Fettsäuremethylester (FAME) überführt. Aus dem per-O-acetylierten t1δ:0 wurde, aufgrund der Oxidation der Diolgruppen zwischen C3 und C4, ein Pentadecansäure-Methylester (C15:0) erhalten. Zusätzlich wurden zwei mittelkettige FAME erhalten und mittels GC-MS als Nonansäure-Methylester (C9:0, 7,5 min) und Decansäure-Methylester (C10:0, 9,0 min) identifiziert. Beide Fettsäuren lagen in einem Verhältnis von 1 :3 vor, woraus folgert, daß in der Originalprobe zwei Phytosphingenin-Isomere (t1δ:18 und t1δ:19) mit unterschiedlicher Lage der Doppelbindung in Position delta-δ und -9 vorlagen. Weiterhin wurden die per-O-acetylierten C1δ-Trihydroxybasen über AgN03- Dünnschichchromatographie (TLC) in 125 μg t1δ:0, 300 μg t18:1trans 8'9 und 100 μg t18:1 cis 8,9 aufgetrennt obwohl die Regioisomere t1δ:1trans 8 und t1δ:1trans 9 bzw. t1δ:1cis8 und t1δ:1cιs9 nicht durch die AgN03-TLC voneinander getrennt wurden, konnte die Bestimmung der eis- (Fig. 10B) und /rans-Stereoisomere (Fig. 10A) mittels NMR durchgeführt werden. Ein- (1D) und zweidimensionale (2D) 1H-NMR- Experimente (COSY) der gereinigten t1δ:1traπs und t1δ:1cιs Stereoisomere wurden durchgeführt. Die t18:1trans -Fraktion wies nicht-distinkte, aber charakteristische Multiplets für die olefinischen ProtonenFor a clear localization of the double bond, the fraction of the C13 trihydroxy bases was oxidized with potassium permanganate and converted into its fatty acid methyl ester (FAME). A methyl pentadecanoate (C15: 0) was obtained from the per-O-acetylated t1δ: 0 due to the oxidation of the diol groups between C3 and C4. In addition, two medium-chain FAME were obtained and identified by GC-MS as nonanoic acid methyl ester (C9: 0, 7.5 min) and decanoic acid methyl ester (C10: 0, 9.0 min). Both fatty acids were present in a ratio of 1: 3, from which it follows that in the original sample there were two phytosphingenin isomers (t1δ: 1 8 and t1δ: 1 9 ) with different positions of the double bond in positions delta-δ and -9. Furthermore, the acetylated per-O-C1δ-Trihydroxybasen on AgN0 3 were - Dünnschichchromatographie (TLC) in 125 ug t1δ: 0, 300 ug t18: 1 trans 8 '9 and 100 ug t18: 1 cis 8,9 separated although the regioisomers t1δ : 1 trans 8 and t1δ: 1 trans 9 or t1δ: 1 cis8 and t1δ: 1 cιs9 were not separated from each other by the AgN0 3 -TLC, the determination of the eis (Fig. 10B) and / rans stereoisomers (Fig 10A) by means of NMR. One (1D) and two-dimensional (2D) 1 H-NMR experiments (COZY) of the purified t1δ: 1 traπs and t1δ: 1 cιs stereoisomers were carried out. The t18: 1 trans fraction showed non-distinct but characteristic multiplets for the olefinic protons
(-CH=CH-) bei 5.036 ppm auf, die im COSY-Experiment Kreuz-Signale zu den α- Methylenprotonen (1.δ79 ppm) zeigen, die charakteristisch für rraπs-olefinische Protonen sind (D. J. Frost et al., The PMR analysis of non-conjugated alkenoic and alkynoic acids and esters, Chem. Phys. Lipis 15: 53-δö (1976)). In der t1δ:1cιs- Fraktion wurden diese Signale leicht in das höhere Feld für die olefinischen Protonen (δ,27δ ppm) verschoben, wohingegen die α-Methylenprotonen in das niedrigere Feld (1 ,927 ppm) verschoben werden, was wiederum characteristisch für das cis- Isomer ist (D. J. Frost et al. (1976), s.o.). Von den relativen Anteilen der vier Derivate kann das Verhältnis aller ungesättigten Phytosphingenin-Isomere bestimmt werden. Bei der GC-MS-Analyse der FAME (C10:0 und C9:0), erhalten nach Kaliumpermanganat-Oxidation, wiesen die beiden Regioisomere ein Verhältnis von 3:1 auf, was für eine dreifach stärkere delta-δ- als delta-9-Desaturase-Aktivität spricht. Die relativen Massenverteilungen der Stereoisomere bei der AgN03-TLC weisen auf eine dreifach höhere Dominanz des rans-lsomers gegenüber der c/s-Desaturase-Aktivität hin. Die heterologe Expression des s/d1-Gens aus A. thaliana in Hefe führte zur Neubildung von vier Phytosphingenin-Isomeren t1δ:18trans, t1δ:19trans, t1δ:18cis und t1δ:19cis im Verhältnis von 9:3:3:1.(-CH = CH-) at 5,036 ppm, which in the COZY experiment show cross signals to the α-methylene protons (1.δ79 ppm), which are characteristic of rraπs-olefinic protons (DJ Frost et al., The PMR analysis of non-conjugated alkenoic and alkynoic acids and esters, Chem. Phys. Lipis 15: 53-δö (1976)). In the t1δ: 1 cιs fraction these signals were shifted slightly into the higher field for the olefinic protons (δ, 27δ ppm), whereas the α-methylene protons were shifted into the lower field (1, 927 ppm), which in turn was characteristic of is the cis isomer (DJ Frost et al. (1976), see above). The ratio of all unsaturated phytosphingenin isomers can be determined from the relative proportions of the four derivatives. In the GC-MS analysis of the FAME (C10: 0 and C9: 0), obtained after oxidation of potassium permanganate, the two regioisomers had a ratio of 3: 1, which means that the delta-δ- is three times stronger than that of delta-9 -Desaturase activity speaks. The relative mass distributions of the stereoisomers in the AgN0 3 -TLC indicate a three-fold higher dominance of the rans isomer over the c / s desaturase activity. The heterologous expression of the s / d1 gene from A. thaliana in yeast led to the new formation of four phytosphingenin isomers t1δ: 1 8trans , t1δ: 1 9trans , t1δ: 1 8cis and t1δ: 1 9cis in a ratio of 9: 3: 3 :1.
Die MS- und NMR-Spektren sind in Fig. 9 und 10 gezeigt.The MS and NMR spectra are shown in Figs. 9 and 10.
Beispiel 6: Klonierung und Transformation von s/d1 in Arabidopsis thaliana Für eine heterologe Überexpression des s/d1-Gens aus ß. napus wurde der 1δ02 bp PCR-Klon 1 in puc19/Smal kloniert (siehe Beispiel 1.) und mit den Restriktiosenzymen BamHI und Sacl geschnitten. Das resultierende 1621 bp DNA- Fragment wurde in Sense-Orientierung in den mit BamHI und Sacl geschnittenen Pflanzenexpressionsvektor pBI121 der Fa. CLONTECH hinter den konstitutiven 35S-Promotor (CaMV), anstelle des GUS-Gens, legiert. Das resultierende Plasmid pBIBδBn ist in Fig. 11 dargestellt.Example 6: Cloning and transformation of s / d1 in Arabidopsis thaliana For heterologous overexpression of the s / d1 gene from ß. The 1δ02 bp PCR clone 1 was cloned into puc19 / Smal (see Example 1) and cut with the restriction enzymes BamHI and SacI. The resulting 1621 bp DNA fragment was alloyed in a sense orientation in the BamBI and Sacl-cut plant expression vector pBI121 from CLONTECH behind the constitutive 35S promoter (CaMV) instead of the GUS gene. The resulting plasmid pBIBδBn is shown in Fig. 11.
Für eine homologe Antisense-Ausschaltung des s/d1-Gens wurde der 1272 bp PCR- Klon 3 aus A. thaliana in pudδ/Smal kloniert (siehe Beispiel 2.) und mit BamHI und Sacl verdaut. Das resultierende 12δ3 bp DNA-Fragment wurde in antisense- Orientierung in die BamHI/Sacl-Schnittstellen des Vektors pBI121 legiert. Das resultierende Plasmid pBIBδAt ist in Abb. 12 dargestellt.For a homologous antisense elimination of the s / d1 gene, the 1272 bp PCR clone 3 from A. thaliana was cloned into pudδ / Smal (see Example 2) and digested with BamHI and Sacl. The resulting 12δ3 bp DNA fragment was alloyed in the antisense orientation in the BamHI / SacI sites of the vector pBI121. The resulting plasmid pBIBδAt is shown in Fig. 12.
Die Plasmide pBIBδBn und pBIBδAt wurden in E. coli XLIblue transformiert und eine DNA-Maxipräparation mit dem Plasmid Maxi Kit (Qiagen) durchgeführt. Die Vollständigkeit und richtige Orientierung der PCR-Klone in pBIBδBn und pBIBδAt wurde einerseits durch verschiedene Restriktionsverdaus (BamHI + Sacl, BamHI + EcoRI; Xbal + Sacl), andererseits durch erneute Teilsequenzierungen überprüft mit dem ABI PRISM Dye Terminator Kit (Perkin-Elmer) bei Tm δO °C und folgenden spezifischen Primern:The plasmids pBIBδBn and pBIBδAt were transformed into E. coli XLIblue and a DNA maxipreparation was carried out with the plasmid Maxi Kit (Qiagen). The completeness and correct orientation of the PCR clones in pBIBδBn and pBIBδAt was checked on the one hand by various restriction digests (BamHI + Sacl, BamHI + EcoRI; Xbal + Sacl) and on the other hand by repeated partial sequencing the ABI PRISM Dye Terminator Kit (Perkin-Elmer) at T m δO ° C and the following specific primers:
3δS-Promotor-Primer PR01: δ'-CACAATCCCACTATCCTT-3' (vorwärts) BN9: δ'-GGAGCTTTGTAAGAAGCAT-3' (revers) und ATδ: 5'-GGAATCTCAATCGCGTGG-3' (revers).3δS promoter primer PR01: δ'-CACAATCCCACTATCCTT-3 '(forward) BN9: δ'-GGAGCTTTGTAAGAAGCAT-3' (reverse) and ATδ: 5'-GGAATCTCAATCGCGTGG-3 '(reverse).
Der Agrobacterium tumefaciens Stammes GV3101 mit dem Ti-Helferplasmid pMP90 (C. Koncz et al., „The promotor of TL-DNA gene δ controls the tissue-specific expression of chimaeric genes by a novel type of Agrobacterium binary vector", Mol. Gen Genet. 204: 363-396 (1986)) wurde mit je einem der binären Vektoren pBI121 (Kontrolle), pBIBδBn und pBIBδAt nach der Methode von H. Chen et al., „Enhanced Recovery of Transformation of Agrobacterium tumefaciens after Freeze-Thaw Transformation and Drug Selection", BioTechniques 16: 664-669 (1994) transformiert. Die transformierten Bakterien wurden 24 h bei 28 °C in Luria-Bertani (LB) Selektivmedium mit 100 μg/ml Rifampicin, 40 μg/ml Gentamycin und 50 μg/ml Kanamycin (Sigma) angezogen. Nach der Antibiotika-Selektion auf LB-Agarplatten wurden positive Einzelkolonien mittels PCR bei Tm 50 °C mit folgenden Primerkombinationen überprüft: PR01 und BN6 für pBIB5Bn; PR01 und AT1 für pBIBδAt. Die Transformation ganzer A. thaliana Pflanzen, Ecotyp Columbia (C24) erfolgte in planta durch /Agroöacter/wm-vermittelte Vakuum Infiltration (N. Bechthold et al. (1993), s.o. und modifiziert von A. F. Bent et al. (1994), s.o.)The Agrobacterium tumefaciens strain GV3101 with the Ti helper plasmid pMP90 (C. Koncz et al., "The promotor of T L -DNA gene δ controls the tissue-specific expression of chimaeric genes by a novel type of Agrobacterium binary vector", Mol. Gen Genet. 204: 363-396 (1986)) was each with one of the binary vectors pBI121 (control), pBIBδBn and pBIBδAt according to the method of H. Chen et al., "Enhanced Recovery of Transformation of Agrobacterium tumefaciens after Freeze-Thaw Transformation and Drug Selection ", BioTechniques 16: 664-669 (1994). The transformed bacteria were grown for 24 h at 28 ° C. in Luria-Bertani (LB) selective medium with 100 μg / ml rifampicin, 40 μg / ml gentamycin and 50 μg / ml kanamycin (Sigma). After the antibiotic selection on LB agar plates, positive single colonies were checked by means of PCR at T m 50 ° C. with the following primer combinations: PR01 and BN6 for pBIB5Bn; PR01 and AT1 for pBIBδAt. The transformation of whole A. thaliana plants, ecotype Columbia (C24) was carried out in planta by / Agroöacter / wm-mediated vacuum infiltration (N. Bechthold et al. (1993), and modified by AF Bent et al. (1994), see above) )
Beispiel 7: Anzucht und Selektion der transgenen rafe/dojPS/s-Pflanzen Die A /rofeacter/üm-infiltrierten TO-Pflanzen wurden in Töpfen mit Einheitserde/Sand (2:1) in der Klimakammer unter Langtagbedingungen (16 h Licht) bei 22 °C Tagesund 17 °C Nachttemperatur und 60% Luftfeuchte bis zur Reife angezogen und die T1 -Samen vereint geerntet. Die getrockneten Samen wurden mit 4 % NaOCI in 0,02 % Triton® X-100 oberflächensterilisiert, auf Selektiv-Nährmedium (1x MS-salts incl. Gamborg's Vit. Bδ, Sigma M6619, 0,0δ % MES-KOH pH δ,8, 1 % Sucrose, 0,δ % Agar) mit 60 μg/ml Kanamycin ausplattiert. Nach einer 2 d Kältebehandlung bei 4 °C, um die Keimung zu synchronisieren, wurden die Platten in die Klimakammer transferiert (s.o.). Nach 14 - 20 d wurden die Kanamycin-resistenten T1 -Pflanzen in Erde umgetopft, als Einzelpflanzen geselbstet und die T2-Samen geerntet. Daraus wurden, wie oben beschrieben (V. Katavic et al., „In planta transformation of Arabidopsis thaliana", Mol. Gen Genet. 245: 363-370 (1994)), wiederum Antibiotika- resistente T2-Pflanzen selektioniert, die in einem Verhältnis hetero- zu homozygoter Pflanzen von 2:1 aufspalten.Example 7: Cultivation and selection of the transgenic rafe / dojPS / s plants The A / rofeacter / um-infiltrated TO plants were grown in pots with uniform earth / sand (2: 1) in the climatic chamber under long-day conditions (16 h light) at 22 ° C day and 17 ° C night temperature and 60% humidity grown to maturity and the T1 seeds harvested together. The dried seeds were surface-sterilized with 4% NaOCI in 0.02% Triton ® X-100, on selective nutrient medium (1x MS salts incl. Gamborg's Vit. Bδ, Sigma M6619, 0.0δ% MES-KOH pH δ, 8 , 1% sucrose, 0, δ% agar) plated with 60 μg / ml kanamycin. After a 2 d cold treatment at 4 ° C to synchronize the germination, the plates were transferred to the climatic chamber (see above). After 14-20 d, the kanamycin-resistant T1 plants were grown in Repotted soil, self-grown as single plants and the T2 seeds harvested. Again, as described above (V. Katavic et al., "In planta transformation of Arabidopsis thaliana", Mol. Gen Genet. 245: 363-370 (1994)), antibiotic-resistant T2 plants were selected, which were found in a Split the ratio of hetero- to homozygous plants from 2: 1.
Beispiel δ: Analyse der LCB aus den Sphingolipiden transgener Arabidopsis- PflanzenExample δ: Analysis of the LCB from the sphingolipids of transgenic Arabidopsis plants
Für die nachfolgenden Analysen der Fettsäuren und langkettigen Basen der Sphingolipide wurden Mischproben ganzer T2-Pflanzen (Blätter und Wurzel) direkt von den Selektivplatten verwendet, die aus der Selbstung unabhängiger T1 -Pflanzen hervorgegangen sind.For the subsequent analyzes of the fatty acids and long-chain bases of the sphingolipids, mixed samples of whole T2 plants (leaves and roots) were used directly from the selective plates, which resulted from the self-cultivation of independent T1 plants.
Nach einer Lipidextraktion ganzer T2-Pflanzen in CHCI3/Methanol/Wasser (2:1 :0,75) wurden die Gesamt-Fettsäuren als Bromphenacylester-Derivate mittels RP-HPLC analysiert (H. P. Haschke et al. (1990), s.o.). Die Analyse transgener T2-Pflanzen, die mit pBIBδBn bzw. pBIBδAt transformiert worden waren, 19 d und 36 d nach Keimung zeigte keine signifikanten Änderungen im Fettsäuremuster gegenüber Wildtyp und Kontrollpflanzen (+ pBI121) und entsprach der Fettsäurezusammensetzung in Arabidopsis- Wildtyp Blättern (B. Lemieux et al., „Mutants of Arabidopsis with alterations in seed lipid fatty acid composition", Theor. Appl. Genet. 80: 234-240 (1990)). Eine dünnschichtchromatographische Auftrennung des Lipidextraktes in Aceton/Toluol/Wasser (91 :30:6) zeigte ebenfalls keine signifikanten Veränderungen des Ceramid- und Cerebrosidgehaltes in T2- Pflanzen 37 d nach Keimung.After lipid extraction of whole T2 plants in CHCI 3 / methanol / water (2: 1: 0.75), the total fatty acids as bromophenacyl ester derivatives were analyzed by RP-HPLC (HP Haschke et al. (1990), see above). Analysis of transgenic T2 plants that had been transformed with pBIBδBn and pBIBδAt, 19 d and 36 d after germination, showed no significant changes in the fatty acid pattern compared to wild type and control plants (+ pBI121) and corresponded to the fatty acid composition in Arabidopsis wild-type leaves (B. Lemieux et al., "Mutants of Arabidopsis with alterations in seed lipid fatty acid composition", Theor. Appl. Genet. 80: 234-240 (1990)). A thin layer chromatographic separation of the lipid extract in acetone / toluene / water (91: 30 : 6) also showed no significant changes in the ceramide and cerebroside content in T2 plants 37 d after germination.
Die Analyse der langkettigen Basen (LCB) aus Sphingolipiden erfolgte wie unter Beispiel 4. beschrieben mit ganzen T2-Pflanzen (Gesamt-Sphingolipide) 19 d, 23 d und 34 d nach Keimung, mit Lipidextrakten (Cerebroside und Ceramide) 21 d und 23 d nach Keimung und mit Lipid-extrahierten T2-Pflanzen (nicht extrahierbare Sphingophosphoglycolipide) 26 d nach Keimung. Die LCB-Analysen der Mischproben zeigten, daß der Gehalt an eis- und frans-Phytosphingenin (t1δ:1) in den Gesamt-Sphingolipiden von δO-δδ % im Wildtyp bzw. in T2-Kontrollpflanzen (+ pBI121) auf bis zu δ % in T2-Pflanzen mit pBIBδAt (Antisense) bzw. pBIBδBn (sense) reduziert wurde (Fig. 13). Während die Antisense-Wirkung in T2- Pflanzen mit pBIBδBn (sense) auf Co-Suppression-Effekte zurückzuführen ist (Review von J. Finnegan et al., „Transgene Inactivation: Plants Fight Back!", BIO/TECHNOLOGY 12: 363-δδδ (1994)), war eine Steigerung des Phytosphingenin- Gehaltes in A. thaliana durch heterologe Überexpression des s/d7-Gens aus ß. napus bei den hohen Ausgangswerten im Wildtyp (s.o.) nur noch um max. 6-9 % möglich. Da der Gehalt und das Verhältnis von eis- und rrans-Phytosphingenin z. B. mit der Pflanzenart variiert (Imai et al., s.o.), würde eine heterologe Überexpression des s/d1 Gens in anderen Organismen zu einer größeren Modifikation der Basenzusammensetzung führen. Weitere Analysen der o. g. Subtraktionen zeigten, daß Cerebroside mehr c/s-Phytosphingenin und Sphingophosphoglycolipide wesentlich mehr Arans-Phytosphingenin enthalten. Während derThe analysis of the long-chain bases (LCB) from sphingolipids was carried out as described in Example 4 with whole T2 plants (total sphingolipids) 19 d, 23 d and 34 d after germination, with lipid extracts (cerebroside and ceramides) 21 d and 23 d after germination and with lipid-extracted T2 plants (non-extractable sphingophosphoglycolipids) 26 d after germination. The LCB analyzes of the mixed samples showed that the content of eis- and frans-phytosphingenin (t1δ: 1) in the total sphingolipids from δO-δδ% in wild type or in T2 control plants (+ pBI121) to up to δ% in T2 plants with pBIBδAt (antisense) or pBIBδBn (sense) was reduced (Fig. 13). While the antisense effect in T2 plants with pBIBδBn (sense) is due to co-suppression effects (Review by J. Finnegan et al., "Transgenic Inactivation: Plants Fight Back!", BIO / TECHNOLOGY 12: 363-δδδ (1994)), an increase in the phytosphingenin content in A. thaliana by heterologous overexpression of the s / d7 gene from ß.napus was only possible by a maximum of 6-9% with the high initial values in the wild type (see above) the content and ratio of eis- and rrans-phytosphingenin varies, for example, with the plant species (Imai et al., see above), a heterologous overexpression of the s / d1 gene in other organisms would lead to a greater modification of the base composition Analyzes of the above subtractions showed that cerebrosides contain more c / s-phytosphingenin and sphingophosphoglycolipids contain significantly more arans-phytosphingenin
Phytosphingeningehalt in den Cerebrosiden relativ konstant gehalten wird, führt der Antisense-Effekt zu einer drastischen Reduktion dieser LCB-Spezies in den Sphingophosphoglycolipiden.If the phytosphinine content in the cerebrosides is kept relatively constant, the antisense effect leads to a drastic reduction of these LCB species in the sphingophosphoglycolipids.
Die chemische Strukturanalyse des Phytosphingenins in Arabidopsis thaliana erfolgte durch direkte Ba(OH)2-Hydrolyse von Wildtyp-Blättern und Extraktion der freien LCB aus dem Hydrolysat (siehe Beispiel 4.). Die C1δ-Trihydroxybasen wurden wie unter Beispiel 5 beschrieben isoliert und entsprechend analysiert. Die NMR- und MS-Analysen ergaben, daß
Figure imgf000029_0001
im Gegensatz zu den transgenen Hefezellen nur das delta-δ-Phytosphingenin (t1δ:18traπs und t1δ:18cis) enthalten. Die HPLC-Analysen der LCB aus \rac»/dops/s-Pflanzen (Fig. δ E) sprechen für ein ähnliches Verhältnis der Stereoisomere (t1δ:1trans und t1δ:1cis ) von 3:1 , wie es bei der heterologen Expression des s/d1-Gens aus A. thaliana in Hefe vorliegt.
The chemical structure analysis of the phytosphinine in Arabidopsis thaliana was carried out by direct Ba (OH) 2 hydrolysis of wild-type leaves and extraction of the free LCB from the hydrolyzate (see Example 4). The C1δ trihydroxy bases were isolated as described in Example 5 and analyzed accordingly. The NMR and MS analyzes showed that
Figure imgf000029_0001
in contrast to the transgenic yeast cells only contain the delta-δ-phytosphingenin (t1δ: 1 8traπs and t1δ: 1 8cis ). The HPLC analyzes of the LCB from \ rac »/ dops / s plants (FIG. Δ E) speak for a similar ratio of the stereoisomers (t1δ: 1 trans and t1δ: 1 cis ) of 3: 1, as is the case with the heterologous Expression of the s / d1 gene from A. thaliana is present in yeast.
Beispiel 9: SubstratspezifitätExample 9: Substrate specificity
Enzymatische Studien haben gezeigt, daß nicht die freien langkettigen Basen, sondern die N-acylierten Basen (Ceramide und komplexe Sphingolipide) desaturiert werden (C. Michel et al., „Characterization of Ceramide Synthesis. A Dihydroceramide Desaturase introduces the 4,5-frat?s-double bond of sphingosine at the level of dihydroceramide", J. Biol. Chem. 272: 22432-22437 (1997); J. K. Kok et al., „Dihydroceramide Biology. Structure-specific metabolism and intracellular localization", J. Biol. Chem. 272:21126-21136 (1997)).Enzymatic studies have shown that not the free long-chain bases, but the N-acylated bases (ceramides and complex sphingolipids) are desaturated (C. Michel et al., "Characterization of Ceramide Synthesis. A Dihydroceramide Desaturase introduces the 4,5-frat ? s-double bond of sphingosine at the level of dihydroceramide ", J. Biol. Chem. 272: 22432-22437 (1997); JK Kok et al.," Dihydroceramide Biology. Structure-specific metabolism and intracellular localization ", J. Biol. Chem. 272: 21126- 21136 (1997)).
Unsere Ergebnisse und die Zusammensetzung der LCB-Spezies in Spingolipiden von Pflanzen (Imai et al., s.o.) zeigen, daß die hier isolierten Nukleinsäuren (s/d1) für eine Sphingolipid-Desaturase codieren, die zur Bildung folgender eis (Z)- und trans (E)-delta-δ-ungesättigter Basen aus D-ety/ 7ro-2-Amino-1 ,3-dihydroxy-octadecan (Sphinganin, d1δ:0), das zum größten Teil außerdem noch delta-4-desaturiert bzw. - hydroxyliert wird, in Pflanzen führt:Our results and the composition of the LCB species in spingolipids from plants (Imai et al., See above) show that the nucleic acids isolated here (s / d1) code for a sphingolipid desaturase which is responsible for the formation of the following eis (Z) - and trans (E) -delta-δ-unsaturated bases from D-ety / 7ro-2-amino-1,3-dihydroxy-octadecane (sphinganine, d1δ: 0), which for the most part also delta-4-desaturates or - is hydroxylated, results in plants:
- D-etyf 7ro-2-Amino-1 ,3-dihydroxy-δ-octadecen (δ-Sphingenin, d1δ:18)D-etyf 7ro-2-amino-1,3-dihydroxy-δ-octadecene (δ-sphingenin, d1δ: 1 8 )
- D-e/yf/7ro-2-Amino-1 ,3-dihydroxy-4(E),δ-octadecadien(4t,δ-Sphingadienin, d1δ:14t'8)De / yf / 7ro-2-amino-1,3-dihydroxy-4 (E), δ-octadecadiene (4t, δ-sphingadienine, d1δ: 1 4t ' 8 )
- D-erytf)ro-2-Amino-1 ,3,4-trihydroxy-3-octadecen (δ-Phytosphingenin, t1δ:18)- D-erytf) ro-2-amino-1, 3,4-trihydroxy-3-octadecen (δ-phytosphingenin, t1δ: 1 8 )
Die Expression der pflanzlichen s/d1 -Nukleinsäuren aus Arabidopsis thaliana und Brassica napus in der Hefe Saccharomyces cerevisiae führt zur Produktion neuartiger eis (Z)- und trans (E)-ungesättigter Basen in diesem Organismus:The expression of the plant s / d1 nucleic acids from Arabidopsis thaliana and Brassica napus in the yeast Saccharomyces cerevisiae leads to the production of novel ice (Z) and trans (E) unsaturated bases in this organism:
- D-eAy#7ro-2-Amino-1 ,3,4-trihydroxy-3-octadecen (δ-Phytosphingenin, t1δ:18)D-eAy # 7ro-2-amino-1, 3,4-trihydroxy-3-octadecen (δ-phytosphingenin, t1δ: 1 8 )
- D-e/yf ]ro-2-Amino-1 ,3,4-trihydroxy-9-octadecen (9-Phytosphingenin, t1δ:19)De / yf] ro-2-amino-1, 3,4-trihydroxy-9-octadecen (9-phytosphingenin, t1δ: 1 9 )
Die Desaturierung von D-eryf/?ro-2-Amino-1 ,3-dihydroxy-octadecan (Sphinganin, d1δ:0) und anschließende delta-4-Hydroxylierung (Haak et al. (1997), s.o.) führt in den transgenen Hefen zum planzentypischen δ-Phytosphingenin, während hier auch die Desaturierung des delta-4-hydroxylierten D-eryf/7ro-2-Amino-1 ,3,4-trihydroxy- octadecans (Phytosphinganin, t1δ:0) möglich ist und so zur Bildung des, in der Natur nicht vorkommenden, 9-Phytosphingenins führt. Daraus folgt, daß das pflanzliche Enzym die neue Doppelbindung im Abstand Δ-6 zu dem letzten Sauerstoffaktivierten C-Atom der LCB (Hydroxygruppe an C3 des Sphinganins bzw. an C4 des Phytosphinganins) einführt (Abb. 14). Transgene T2-Pflanzen, die mit pBIBδBn, pBIBδAt bzw. pBI121 transformiert worden waren, wiesen das unveränderte Fettsäuremuster des Wildtyps auf, der keine γ- Linolensäure und damit auch keine delta-6-Desaturase-Aktivität aufweist (Lemieux et al. (1990), s.o.). Wie für die transgenen Pflanzen unter Beispiel δ. beschrieben, wurden Gesamtfettsäure-Analysen von induzierten Hefezellen durchgeführt, die mit pYES2Bn, pYES2At oder pYES2 transformiert worden waren (siehe Beispiel 3). Die Analysen der drei Kulturen zeigten das mit dem Wildtyp identische Fettsäuremuster, wodurch eine delta-12-Desaturierung zu Hexadecadien- und Linolsäure ausgeschlossen werden konnte. Transformierte und Wildtyphefen, die exogen applizierte 9, 12-Linolsäure in ihre Glycerolipide inkorporieren, zeigten keine delta- 1δ- oder delta-6-Desaturase-Aktivität, die zur Bildung von α- bzw. γ-Linolensäure geführt hätte (Girke et al., „Identification of a novel Δ6-acyl-lipid-desaturase by targeted gene disruption in Physcomitrella patens", Plant J., in press). Die hier identifizierte Sphingolipid-Desaturase unterscheidet sich eindeutig von einer delta-6- c/s-Glycerolipid-Desaturase, hinsichtlich ihrer Regio-, Stereo- und Substratspezifität. Desaturation of D-eryf /? Ro-2-amino-1, 3-dihydroxy-octadecane (sphinganine, d1δ: 0) and subsequent delta-4-hydroxylation (Haak et al. (1997), see above) leads to the transgenic Yeasts for the plant-typical δ-phytosphingenin, while the desaturation of the delta-4-hydroxylated D-eryf / 7ro-2-amino-1, 3,4-trihydroxy-octadecane (phytosphinganine, t1δ: 0) is also possible and thus for formation of 9-phytosphinine, which does not occur in nature. It follows that the plant enzyme introduces the new double bond at a distance of Δ-6 from the last oxygen-activated carbon atom of the LCB (hydroxy group at C3 of sphinganine or at C4 of phytosphinganine) (Fig. 14). Transgenic T2 plants that had been transformed with pBIBδBn, pBIBδAt or pBI121 showed the unchanged fatty acid pattern of the wild type, which has no γ-linolenic acid and therefore also no delta-6-desaturase activity (Lemieux et al. (1990) , see above). As for the transgenic plants under example δ. described, total fatty acid analyzes were carried out on induced yeast cells which had been transformed with pYES2Bn, pYES2At or pYES2 (see Example 3). The analyzes of the three cultures showed that the fatty acid pattern was identical to that of the wild type, whereby delta-12 desaturation to hexadecadiene and linoleic acid could be excluded. Transformed and wild-type yeasts that incorporate exogenously applied 9, 12-linoleic acid into their glycerolipids showed no delta-1δ- or delta-6-desaturase activity that would have resulted in the formation of α- or γ-linolenic acid (Girke et al. "Identification of a novel Δ6-acyl-lipid desaturase by targeted gene disruption in Physcomitrella patens", Plant J., in press). The sphingolipid desaturase identified here clearly differs from a delta-6 c / s glycerolipid -Desaturase, with regard to its regional, stereo and substrate specificity.

Claims

Patentansprücheclaims
1. Sphingolipid-Desaturase die selektiv eine Doppelbindung in die Sphingobase des Ceramidrestes von Sphingolipiden und von Capnoiden einführt.1. Sphingolipid desaturase which selectively introduces a double bond into the sphingobase of the ceramide residue of sphingolipids and of capnoids.
2. Sphingolipid-Desaturase gemäß Anspruch 1 , die eine Doppelbindung in Position C6-C nach dem letzten sauerstoffaktivierten Kohlenstoffatom (Ci) der Sphingobase einführt.2. Sphingolipid desaturase according to claim 1, which introduces a double bond in position C 6 -C after the last oxygen-activated carbon atom (Ci) of the sphingobase.
3. Sphingolipid-Desaturase gemäß Anspruch 1 oder 2, wobei die Aminosäuresequenz der Desaturase eines oder mehrere der Fragmente a) - c) umfaßt: a) HD[A,S]GH, b) HNAHH und c) QLEHH .3. Sphingolipid desaturase according to claim 1 or 2, wherein the amino acid sequence of the desaturase comprises one or more of the fragments a) - c): a) HD [A, S] GH, b) HNAHH and c) QLEHH.
4. Sphingolipid-Desaturase gemäß Anspruch 3, wobei die Aminosäuresequenz der Desaturase eine oder mehrere der Fragmente c) - e) umfaßt: c) QLEHH d) AYXaXbHD[A,S]GH, wobei Xa und Xb beliebige Aminosäurereste sind, und e)THNAHH.4. Sphingolipid desaturase according to claim 3, wherein the amino acid sequence of the desaturase comprises one or more of the fragments c) - e): c) QLEHH d) AYX a X b HD [A, S] GH, where X a and X b any Are amino acid residues, and e) THNAHH.
δ. Sphingolipid-Desaturase gemäß Anspruch 4, wobei das Fragment d) die Aminosäuresequenz AYXaGHDAGH aufweist, worin Xa ein beliebiger Aminosäurerest ist. δ. Sphingolipid desaturase of claim 4, wherein the fragment d) comprises the amino acid sequence AYX a GHDAGH, wherein X a is any amino acid residue.
6. Sphingolipid-Desaturase gemäß Anspruch 3, 4 oder 5, wobei die Aminosäuresequenz der Desaturase alle drei Fragmente a)- c) oder c) - e) umfaßt.6. sphingolipid desaturase according to claim 3, 4 or 5, wherein the amino acid sequence of the desaturase comprises all three fragments a) - c) or c) - e).
7. Sphingolipid-Desaturase gemäß einem oder mehreren der Ansprüche 3 bis 6, wobei die Aminosäuresequenz der Desaturase weiterhin die Aminosäuresequenz AWWKWT und/oder FGGLQF umfaßt.7. sphingolipid desaturase according to one or more of claims 3 to 6, wherein the amino acid sequence of the desaturase further comprises the amino acid sequence AWWKWT and / or FGGLQF.
δ. Sphingolipid-Desaturase gemäß einem oder mehreren der Ansprüche 1 bis 7, wobei die Desaturase eine der in Fig. 2 oder 4 gezeigten Aminosäuresequenzen umfaßt.δ. Sphingolipid desaturase according to one or more of claims 1 to 7, wherein the desaturase comprises one of the amino acid sequences shown in Fig. 2 or 4.
9. DNA-Sequenz, die für eine Sphingolipid-Desaturase gemäß einem oder mehreren der Ansprüche 1 bis δ codiert.9. DNA sequence coding for a sphingolipid desaturase according to one or more of claims 1 to δ.
10. DNA-Sequenz gemäß Anspruch 9, die aus Arabidopsis thaliana, Brassica napus erhältlich ist.10. DNA sequence according to claim 9, which is obtainable from Arabidopsis thaliana, Brassica napus.
11. DNA-Sequenz gemäß Anspruch 9 oder 10, die die in Fig. 1 oder 3 gezeigten Nukleotidsequenzen umfaßt.11. DNA sequence according to claim 9 or 10, which comprises the nucleotide sequences shown in Fig. 1 or 3.
12. Vektor umfassend eine DNA-Sequenz gemäß einem oder mehreren der Ansprüche 9 bis 11.12. Vector comprising a DNA sequence according to one or more of claims 9 to 11.
13. Vektor gemäß Anspruch 12, in dem die DNA-Sequenz mit einem Promotor und optional mit einem Terminationssignal funktional verknüpft ist.13. Vector according to claim 12, in which the DNA sequence is functionally linked to a promoter and optionally to a termination signal.
14. Zelle, die mit einem Vektor gemäß Anspruch 12 oder 13 transformiert ist.14. A cell transformed with a vector according to claim 12 or 13.
15. Zelle gemäß Anspruch 14, die eine Planzen-, Pilz-, Bakterien- oder Tierzelle ist.15. A cell according to claim 14 which is a plant, fungal, bacterial or animal cell.
16. Transgener Organismus, der a) eine DNA-Sequenz gemäß einem oder mehreren der Ansprüche 9 bis 11 umfaßt, b) einen Vektor gemäß Anspruch 12 oder 13 umfaßt und/oder c) aus einer Zelle gemäß Anspruch 14 oder 15 generierbar ist.16. A transgenic organism which comprises a) a DNA sequence according to one or more of claims 9 to 11, b) a vector according to claim 12 or 13 and / or c) can be generated from a cell according to claim 14 or 15.
17. Transgener Organismus gemäß Anspruch 16, der eine Planze, Pilz, Bakterium oder Tier ist.17. A transgenic organism according to claim 16 which is a plant, fungus, bacterium or animal.
16. Pflanze oder deren Nachkommschaft, die aus der Pflanzenzelle gemäß Anspruch 14 oder 1δ generierbar ist.16. Plant or its progeny that can be generated from the plant cell according to claim 14 or 1δ.
19. Pflanze gemäß Anspruch 16, die eine Nutzpflanze ist.19. The plant of claim 16 which is a crop.
20. Pflanze gemäß Anspruch 1δ oder 19, die ein verändertes delta-δ-Basenmuster in ihren Sphingolipiden aufweist.20. A plant according to claim 1δ or 19, which has an altered delta-δ base pattern in its sphingolipids.
21. Verfahren zur Herstellung von Pflanzen die einen erhöhten oder reduzierten Anteil oder ein verändertes cis/trans-Verhältnis an delta-δ-ungesättigten langkettigen Basen aufweisen, umfassend a) die Transformation einer Pflanzenzelle mit einer DNA-Sequenz gemäß einem oder mehreren der Ansprüche 9 - 11 oder mit einem Vektor gemäß Anspruch 12 oder 13 und b) die Regeneration einer Pflanze mit verändertem delta-δ-Basenmuster in ihren Sphingolipiden.21. A method for producing plants which have an increased or reduced proportion or a changed cis / trans ratio of delta-δ-unsaturated long-chain bases, comprising a) transforming a plant cell with a DNA sequence according to one or more of claims 9 11 or with a vector according to claim 12 or 13 and b) the regeneration of a plant with an altered delta-δ base pattern in its sphingolipids.
22. Verfahren gemäß Anspruch 21 , wobei die Pflanze eine Nutzpflanze ist.22. The method of claim 21, wherein the plant is a crop.
23. Verfahren gemäß Anspruch 21 oder 22, das a) zum Kompensieren eines Mangels an delta-δ-ungesättigten langkettigen Basen in einem Organismus b) zum Ausschalten der Produktion an delta-δ-ungesättigten Basen, c) zur Herstellung von Pflanzen mit verbesserter Toleranz und Resistenz gegenüber Bodenversalzung und/oder lonenstress bzw. -toxizität und/oder Trockenheit und/oder Feuchte und /oder Kälte bzw. Frost und pflanzenpathogenen Mikroorganismen und d) zur Herstellung von Pflanzen mit geändertem Größenwachstum und Blütezeit geeignet ist.23. The method according to claim 21 or 22, which a) to compensate for a lack of delta-δ-unsaturated long-chain bases in an organism b) to switch off the production of delta-δ-unsaturated bases, c) to produce plants with improved tolerance and resistance to salinity and / or ion stress or toxicity and / or drought and / or moisture and / or cold or frost and phytopathogenic microorganisms and d) for the production of plants with changed size growth and flowering time suitable is.
24. Verfahren zur Herstellung von Sphingolipiden und von Capnoiden mit ungesättigter Sphingobase, umfassend das Kultivieren von Zellen gemäß Anspruch 14 oder 16, von transgenen Organismus gemäß Anspruch 16 oder 17 oder von Pflanzen gemäß einem oder mehreren der Ansprüche 1δ bis 21.24. A method for producing sphingolipids and capnoids with unsaturated sphingobase, comprising culturing cells according to claim 14 or 16, transgenic organism according to claim 16 or 17 or plants according to one or more of claims 1δ to 21.
2δ. Verfahren gemäß Anspruch 24, wobei das hergestellte Sphingolipid oder Capnoid die Formel (I)2δ. The method of claim 24, wherein the sphingolipid or capnoid produced has the formula (I)
Figure imgf000035_0001
Figure imgf000035_0001
aufweist, worinhas, wherein
R1 -OH, -OPO3HR6, ein Kohlenhydratrest oder -S03H ist;R 1 is -OH, -OPO 3 HR 6 , a carbohydrate residue or -S0 3 H;
R2 ein Cι-C33-Alkylrest ist, der ein- oder mehrfach ungesättigt und/oder mit einem oder mehreren Hydroxylresten substituiert sein kann;R 2 is a -CC 33 alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more hydroxyl radicals;
R3 und R5 unabhängig voneinander -H oder -OH sind, oder R3 und R5 zusammen eine trans-Doppelbindung bilden;R 3 and R 5 are independently -H or -OH, or R 3 and R 5 together form a trans double bond;
R4 -H oder ein Cι-Cι5-Alkylrest ist, der ein- oder mehrfach ungesättigt und/oder mit einem oder mehreren Methylresten substituiert sein kann;R 4 is -H or a -CC 5 -alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more methyl radicals;
R6 -H, ein Polyhydroxyalkylrest, ein Aminoalkylrest oder ein Kohlenhydratrest ist; und entweder a, b oder c eine Doppelbindung ist, wobei,R 6 is -H, a polyhydroxyalkyl group, an aminoalkyl group or a carbohydrate group; and either a, b or c is a double bond,
(a) wenn R3 und R5 -H sind, a eine Doppelbindung ist, und(a) when R 3 and R 5 are -H, a is a double bond, and
(b) wenn R3 -OH ist und R5 -H ist, a oder b eine Doppelbindung ist.(b) when R 3 is -OH and R 5 is -H, a or b is a double bond.
26. Verfahren gemäß Anspruch 2δ, wobei R3 ein Cιo-C2 -Alkylrest ist und R4 ein C3-C1 -Alkylrest ist. 26. The method according to claim 2δ, wherein R 3 is a Cιo-C 2 alkyl radical and R 4 is a C 3 -C 1 alkyl radical.
27. Verfahren gemäß Anspruch 2δ, wobei das hergestellte Sphingolipid oder Capnoid die Formel (II)27. The method according to claim 2δ, wherein the sphingolipid or capnoid produced has the formula (II)
Figure imgf000036_0001
Figure imgf000036_0001
aufweist, worin R1, R2, R3, a und b die in Anspruch 2δ angegebene Bedeutung haben.has, wherein R 1 , R 2 , R 3 , a and b have the meaning given in claim 2δ.
2δ. Verfahren gemäß Anspruch 2δ, wobei das hergestellte Sphingolipid oder Capnoid eine Sphingobase, ausgewählt aus:2δ. The method of claim 2δ, wherein the sphingolipid or capnoid produced is a sphingobase selected from:
D-e/y#7ro-2-Amino-1 ,3,4-trihydroxy-(δZ)-octadecen (t18: 1 8cv )D-e / y # 7ro-2-amino-1, 3,4-trihydroxy- (δZ) -octadecene (t18: 1 8cv)
D-e/y ?ro-2-Amino-1 ,3,4-trihydroxy-(8E)-octadecen (t1δ:1 8°tlχ)De / y? Ro-2-amino-1, 3,4-trihydroxy- (8E) -octadecene (t1δ: 1 8 ° t l χ)
D-e/y/- 7ro-2-Amino-1 ,3,4-trihydroxy-(9Z)-octadecen (t1 δ: 1 9 acς<)De / y / - 7ro-2-amino-1, 3,4-trihydroxy- (9Z) -octadecen (t1 δ: 1 9 a c ς < )
D-eryr7/"θ-2-Amino-1 ,3,4-trihydroxy-(9E)-octadecen
Figure imgf000036_0002
enthält.
D-eryr7 / "θ-2-amino-1, 3,4-trihydroxy- (9E) octadecene
Figure imgf000036_0002
contains.
29. Sphinglipid oder Capnoid mit ungesättigter Sphingobase mit der Formel (I):29. Sphinglipid or capnoid with unsaturated sphingobase with the formula (I):
Figure imgf000036_0003
Figure imgf000036_0003
(l).(l).
worin R1 -OH, -OP03HR6, ein Kohlenhydratrest oder -S03H ist;wherein R 1 is -OH, -OP0 3 HR 6 , a carbohydrate residue or -S0 3 H;
R2 ein Cι-C33-Alkylrest ist, der ein-oder mehrfach ungesättigt und/oder mit einem oder mehreren Hydroxylresten substituiert sein kann;R 2 is a C 1 -C 33 -alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more hydroxyl radicals;
R3 und R5 unabhängig voneinander -H oder -OH sind, oder R3 und R5 zusammen eine trans-Doppelbindung bilden;R 3 and R 5 are independently -H or -OH, or R 3 and R 5 together form a trans double bond;
R4 -H oder ein Cι-Cι5-Alkylrest ist, der ein- oder mehrfach ungesättigt und/oder mit einem oder mehreren Methylresten substituiert sein kann;R 4 is -H or a -CC 5 -alkyl radical which can be mono- or polyunsaturated and / or substituted with one or more methyl radicals;
R6 -H, ein Polyhydroxyalkylrest, ein Aminoalkylrest oder ein Kohlenhydratrest ist; und entweder a, b oder c eine Doppelbindung ist, wobei,R 6 is -H, a polyhydroxyalkyl group, an aminoalkyl group or a carbohydrate group; and either a, b or c is a double bond,
(a) wenn R3 und R5 -H sind, a eine Doppelbindung ist,(a) when R 3 and R 5 are -H, a is a double bond,
(b) wenn R3 -OH ist und R5 -H ist, a oder b eine Doppelbindung ist, und(b) when R 3 is -OH and R 5 is -H, a or b is a double bond, and
(c) wenn R4 ein C7-, C9- oder Cn-Alkylrest ist, a keine Doppelbindung ist, und Derivate derselben.(c) when R 4 is C 7 , C 9 or Cn alkyl, a is not a double bond, and derivatives thereof.
30. Sphingolipid oder Capnoid gemäß Anspruch 29 mit der Formel (III):30. Sphingolipid or capnoid according to claim 29 with the formula (III):
Figure imgf000037_0001
Figure imgf000037_0001
(III),(III),
wobei R1, R2, R3, R4, R5, b und c die in Anspruch 29 angegebene Bedeutung haben.wherein R 1 , R 2 , R 3 , R 4 , R 5 , b and c have the meaning given in claim 29.
31. Kosmetikum, Arznei- oder Nahrungsmittel oder chemischer Rohstoff, umfassend31. A cosmetic, pharmaceutical or food or chemical raw material comprising
(a) ein gemäß Anspruch 24 bis 23 hergestelltes Sphingolipid oder Capnoid oder(a) a sphingolipid or capnoid or produced according to claims 24 to 23
(b) ein Sphingolipid oder Capnoid gemäß Anspruch 29 oder 30. (b) a sphingolipid or capnoid according to claim 29 or 30.
PCT/DE1999/001859 1998-06-27 1999-06-25 Sphingolipid-desaturase WO2000000593A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU54075/99A AU5407599A (en) 1998-06-27 1999-06-25 Sphingolipid-desaturase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19828850.6 1998-06-27
DE19828850A DE19828850A1 (en) 1998-06-27 1998-06-27 New sphingolipid desaturase that selectively introduces double bond into sphingolipids and capnoids

Publications (2)

Publication Number Publication Date
WO2000000593A2 true WO2000000593A2 (en) 2000-01-06
WO2000000593A3 WO2000000593A3 (en) 2000-08-10

Family

ID=7872312

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/001859 WO2000000593A2 (en) 1998-06-27 1999-06-25 Sphingolipid-desaturase

Country Status (3)

Country Link
AU (1) AU5407599A (en)
DE (1) DE19828850A1 (en)
WO (1) WO2000000593A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858383B2 (en) 2000-12-22 2005-02-22 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
WO2007066595A1 (en) * 2005-12-05 2007-06-14 Suntory Limited Process for production of ceramide using transformed yeast
US7829674B2 (en) 2006-10-27 2010-11-09 Lpath, Inc. Compositions and methods for binding sphingosine-1-phosphate
US8835715B1 (en) * 2000-06-30 2014-09-16 Basf Plant Science Gmbh Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
US9217749B2 (en) 2006-05-31 2015-12-22 Lpath, Inc. Immune-derived moieties reactive against lysophosphatidic acid
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10045499B2 (en) 2012-05-24 2018-08-14 Iowa State University Research Foundation, Inc. Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants
CN106754769B (en) * 2016-12-01 2019-08-23 中国科学院华南植物园 A kind of tomato Inappropriate ADH syndrome gene and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021022A2 (en) * 1994-12-30 1996-07-11 Rhone-Poulenc Agrochimie Production of gamma linolenic acid by a δ6-desaturase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021022A2 (en) * 1994-12-30 1996-07-11 Rhone-Poulenc Agrochimie Production of gamma linolenic acid by a δ6-desaturase

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
NAPIER, J. A. (1) ET AL: "Cytochrome b5 fusion proteins: A new class of higher plant fatty acid desaturases." JOURNAL OF EXPERIMENTAL BOTANY, (MAY, 1998) VOL. 49, NO. SUPPL., PP. 15. MEETING INFO.: THE SOCIETY FOR EXPERIMENTAL BIOLOGY ANNUAL MEETING LONDON, ENGLAND, UK MARCH 22-27, 1998 SOCIETY FOR EXPERIMENTAL BIOLOGY., XP002132573 *
SCHMIDT, HERMANN (1) ET AL: "Purification and PCR-based cDNA cloning of a plastidial n-6 desaturase." PLANT MOLECULAR BIOLOGY, (1994) VOL. 26, NO. 2, PP. 631-642., XP002132574 *
SPERLING, PETRA ET AL: "A cytochrome-b5-containing fusion protein similar to plant acyl lipid desaturases" EUR. J. BIOCHEM. (1995), 232(3), 798-805, XP002132571 in der Anmeldung erw{hnt *
SPERLING, PETRA ET AL: "A sphingolipid desaturase from higher plants. Identification of a new cytochrome b5 fusion protein" J. BIOL. CHEM., 273(44), 28590-28596, 30. Oktober 1998 (1998-10-30), XP002132572 in der Anmeldung erw{hnt *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9611441B2 (en) 1999-07-06 2017-04-04 Basf Plant Science Gmbh Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids
US8835715B1 (en) * 2000-06-30 2014-09-16 Basf Plant Science Gmbh Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids
US6881546B2 (en) 2000-12-22 2005-04-19 Medlyte, Inc., Sdsu Heart Institute Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
US7169390B2 (en) 2000-12-22 2007-01-30 Lpath Therapeutics, Inc. Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
US6858383B2 (en) 2000-12-22 2005-02-22 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
US7901682B2 (en) 2000-12-22 2011-03-08 Lpath, Inc. Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
WO2007066595A1 (en) * 2005-12-05 2007-06-14 Suntory Limited Process for production of ceramide using transformed yeast
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US9217749B2 (en) 2006-05-31 2015-12-22 Lpath, Inc. Immune-derived moieties reactive against lysophosphatidic acid
US7829674B2 (en) 2006-10-27 2010-11-09 Lpath, Inc. Compositions and methods for binding sphingosine-1-phosphate
US8067549B2 (en) 2006-10-27 2011-11-29 Lpath, Inc. Humanized antibodies and compositions for binding sphingosine-1-phosphate
US8026342B2 (en) 2006-10-27 2011-09-27 Lpath, Inc. Compositions and methods for binding sphingosine-1-phosphate
US8025877B2 (en) 2006-10-27 2011-09-27 Lpath, Inc. Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate
US7956173B2 (en) 2006-10-27 2011-06-07 Lpath, Inc. Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

Also Published As

Publication number Publication date
AU5407599A (en) 2000-01-17
DE19828850A1 (en) 1999-12-30
WO2000000593A3 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
DE69930165T2 (en) HUMAN DELTA 5 DESATURASE GEN
DE69133283T2 (en) DNA CODING FOR VEGETABLE THIOESTERASES
DE60034224T2 (en) NUCLEIC ACID SEQUENCES FOR PROTEINS INVOLVED IN ISOPRENOID SYNTHESIS
DE69233459T2 (en) PREPARATION OF GAMMA LINOLIC ACID BY A DELTA-6 DESATURASE
DE69433941T2 (en) GENE FOR THE FATTY ACID DESATURASE, SAID GENE VECTOR, A PLANT IN WHICH THE SAID GENERAL IS INTRODUCED, AND A METHOD OF CREATING A FOLLOWED PLANT
DE69535064T2 (en) PREPARATION OF GAMMA LINOLINE CAUSE THROUGH A DELTA 6 DESATURASE
DE69333034T2 (en) Modification of vegetable oils using desaturase
DE69836133T2 (en) Plant genes coding for fatty acid epoxidase and their uses
EP1506289B1 (en) Methods for increasing oil content in plants
WO2001051647A2 (en) Method for increasing the content of fatty acids in plants and micro-organisms
WO1995034654A1 (en) Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
DE102004017370A1 (en) PUFA-PKS Genes from Ulkenia
DE60129011T2 (en) NUCLEIC ACID SEQUENCES FOR PROTEINS INVOLVED IN TOCOPHEROL BIOSYNTHESIS
DE69725841T2 (en) NEW PLANT ENZYME AND ITS USE
WO2000000593A2 (en) Sphingolipid-desaturase
EP1948805A1 (en) Method for increasing the total oil content in oil plants
EP2753685A1 (en) Increasing the lipid content in microalgae by genetically manipulating a triacylglycerol (tag) lipase
DE69534849T2 (en) PREPARATION OF HYDROXYLATED FATTY ACIDS IN GENETICALLY MODIFIED PLANTS
DE19752647C1 (en) Reduction of the chlorophyll content in oil plant seeds
WO2003012091A2 (en) Fatty acid desaturase gene obtained from pomegranate and method for the production of unsaturated fatty acids
DE4433307A1 (en) An isolated nucleic acid fragment and products derived from it
EP1412488B1 (en) Method for producing arachidonic acid in transgenic organisms
EP1492872B1 (en) Expression of phospholipid:diacylglycerine acyltransferase (pdat) for the production of plant storage lipids with polyunsaturated fatty acids
DE69931579T2 (en) GENEATING FOR A PROTEIN WITH AURON-SYNTHETIZING ACTIVITY.
EP1025248A1 (en) Reduction of chlorophyll content in oil plant seeds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN CZ HU JP MX PL US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA CN CZ HU JP MX PL US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase